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ABSTRACT 
EFFECTS OF PERMETHRIN, A PYRETHROID INSECTICIDE, ON GLUCOSE AND 
LIPID METABOLISM  
MAY 2017 
XIAO XIAO, B.S., HUNAN AGRICULTURAL UNIVERSITY, CHINA 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Yeonhwa Park 
Over the last few decades, the decline of using organochlorine and 
organophosphorus insecticides has partially contributed to the rising utilization of newer 
synthetic insecticides, which are considered as less harmful and more environmental 
friendly than the older generation of insecticides. Pyrethroid insecticides are one of the 
newer insecticide classes reported with better biodegradability and low mammalian 
toxicity without sacrificing its insecticidal efficacy. Permethrin is one of the most widely 
used pyrethroid insecticides with structural similarity with natural pyrethrin insecticide 
from the flowers of Chrysanthemum cinerariifolium. Since its introduction in the 1970’s, 
permethrin has been extensively used in medicine, military, household, industry and 
agriculture. Although a large body of evidence have supported that exposure to 
organochlorine and organophosphorus insecticides could increase the risk of developing 
obesity and diabetes, less attention has been drawn to pyrethroids. It has been reported 
recently that permethrin potentiated adipogenesis and insulin resistance in vitro. This 
study is designed to determine the effects of exposure to permethrin, along with the 
interaction with high-fat diet, on glucose and lipid metabolism in vivo. Our results 
demonstrated that chronic exposure to low level of permethrin could disturb glucose and 
lipid metabolisms in female and male mice in a diet-dependent manner. Exposure to 
vii 
permethrin significantly increased insulin resistance in male and female mice fed high-fat 
diet as demonstrated by impaired insulin sensitivity, glucose tolerance and increased 
HOMA-IR. Permethrin treatment also significantly increased weight gain and adipose 
tissue weight in high-fat fed male mice but not female mice. Further mechanistic studies 
in mice showed that permethrin can target AMPK pathway, AKT pathway, and fatty acid 
oxidation to influence glucose and lipid metabolisms. In vivo studies in 3T3-L1 
adipocytes showed that permethrin potentiated adipogenesis via calcium- and 
endoplasmic reticulum (ER) stress- mediated mechanisms. The current results suggest 
that exposure to permethrin can potentially disturb glucose and lipid metabolisms 
resulting in increased risk of developing obesity and type 2 diabetes.  
 
 
Key words: Pyrethroids, permethrin, obesity, type 2 diabetes, adipogenesis, insulin 
resistance. 
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CHAPTER 1 
 
INTRODUCTION 
Obesity is associated with energy imbalance with increased energy intake and 
reduced energy expenditure. Western diet, sedentary lifestyle, genetic defects and 
socioeconomic status have been widely accepted as the contributing factors linked with 
the pathogenesis of obesity. Type 2 diabetes are often associated with obesity, marked by 
elevated blood glucose level and insulin resistance 1. More recently, a growing body of 
evidence has suggested that exposure to environmental pollutants, including insecticides, 
are linked with increased risk of obesity and type 2 diabetes 2-13. Along with our 
continuing efforts to find bioactive food compounds to fight against obesity and diabetes, 
searching the contributing factors of these diseases can create new opportunities to 
protect the health and wellness of human beings. 
Permethrin [(±)-3-Phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-
dimethylcyclopropanecarboxylate] is one of the synthetic pyrethroid insecticides 
structurally based on the natural pyrethrins. First synthesized in 1973 and marketed in 
1977, permethrin exhibits environmental stability and excellent potency against a wide 
spectrum of insect pests, while retaining a large margin of mammalian safety 14-16. 
The insecticidal mechanism of action of permethrin relies on its ability to elicit a 
rapid functional disruption in the neuromuscular system by membrane depolarization. 
Permethrin is known to slow the inactivation of voltage sensitive sodium channel 
(VSSC), a pore forming transmembrane protein that consists of four homologous 
domains (I-IV) 14, 17, 18.  
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In mammals, permethrin can be quickly biotransformed by ester cleavage and 
oxidation reactions and almost completely eliminated via urinary and fecal excretions 
within 12 days 16. In the environment, permethrin can be degraded and disappeared 
rapidly (several hours to 58 days) by photolysis, microbial and plant biotranformations 16.   
Based on these characteristics, permethrin became the first pyrethroid to be used 
to protect agricultural crops, public and animal health in the US 15, 18. In the US alone, 
~2.2 million lbs of permethrin have been sprayed annually to agricultural plots, 
residential areas and specific sites important to public health. Approximately 63% of this 
amount of permethrin is applied to residential areas 19. Permethrin has been formulated in 
pet products and veterinary medications to control ectoparasitic arthropod pests, 
including over-the-counter formulations to control human head lice 20, 21. Additionally, 
many biting arthropods show avoidance behaviors to permethrin, hence many permethrin 
treated materials (e.g., permethrin impregnated clothing including military uniforms, pet 
collars, and mosquito nets) have been developed and used to repel blood feeding 
arthropods 22. The wide-spread use of those pyrethroids suggests that human exposure to 
permethrin is quite likely. 
Previously, permethrin was reported to promote adipogenesis and induce insulin 
resistance in cell culture models similar to other types of insecticides 23-26; however, there 
is a lack of in vivo study determining the effect of permethrin on glucose and lipid 
metabolisms. In addition, the molecular mechanisms regarding how permethrin 
potentiated adipogenesis and insulin resistance in vitro have not been fully explored.  
Thus, the purpose of this study was to investigate the effects of permethrin exposure on 
development of dietary-fat-induced obesity and type 2 diabetes in both female and male 
 3 
mice. The molecular mechanisms of permethrin-potentiated adipogenesis in 3T3-L1 
adipocytes were also studied.  
  
 4 
CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 Insecticide introduction and classification  
Insecticides, which are mostly neurotoxins, are a group of substances used to kill 
insect pests that are harmful to humans, crops, livestock, and pets 27. The use of 
insecticides can be dated back to ancient civilization. The Sumerians used sulphur 
compounds against insects and mites around 4,500 years ago and the Chinese used 
arsenical compounds and mercury to control body lice about 3,200 years ago 28. In the 
20th century, the rise of modern synthetic chemistry and the demand for more food has 
contributed to the rising use and syntheses of numerous organic insecticides 29.  
Insecticides can be classified based primarily on their chemical structures and 
mode of actions. Major classes of insecticides include organochlorines, 
organophosphorus, carbamates, pyrethroids, and neonicotinoids. Organochlorine 
insecticides were introduced in the 1940s, followed by organophosphorus insecticides 
(1950s), carbamates (1960s), pyrethroids (1970s), and neonicotinoids (1990s) 27. A few 
examples of each type are shown in Table 2.1.  
Table 2.1. Major classes of insecticides with examples  
Organochlorines Organophosphorus Carbamates Pyrethroids Neonicotinoids 
Aldrin Chlorpyrifos Aldicarb Allethrin Acetamiprid 
DDT/DDE Diazinon Bendiocard Bifenthrin Clothanidin 
Dieldrin Dichlorvos Carbaryl Cismethrin Dinotefuran 
Heptachlor Malathion Dioxacarb Cyhalothrin Imidacloprid 
Lindane Parathion Fenobucarb Deltamethrin Niternpyram 
Methoxychlor Profenofos Isoprocarb Permethrin Thiacloprid 
  Methomyl Tefluthrin Thiamethoxam 
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Most of the organochlorine insecticides are extremely lipophilic and chemically 
stable 30. Organochlorine insecticides can be divided into dichlorodiphenyltrichloroethane 
(DDT)-type and chlorinated alicyclic-type (cyclodienes) based on their distinctive 
mechanisms of action. DDT-type insecticides (such as DDT and dicofol) are known to 
inhibit the closing of voltage-sensitive sodium channel (VSSC) in neurons, resulting in 
repetitive firing of action potentials, while chlorinated alicyclic-type insecticides (e.g. 
aldrin, dieldrin, heptachlor, and endosulfan) bind to γ-aminobutyric acid (GABA) 
chloride ionophore complex, which inhibits chloride influx into the nerve 30, 31. DDT was 
once the most popular insecticide used in the 1940s to 1960s to reduce insect-born 
disease, such as malaria, yellow fever, and typhus, because of its broad-spectrum activity 
against insects and its relatively low mammal toxicity 32, 33. DDE, also used as an 
insecticide, is the major biological metabolite and environmental breakdown product of 
DDT. Due to their toxicity on wild bird populations and high stability in the environment, 
most developed countries have banned the use of DDT and other chlorinated 
hydrocarbons, including the United States in 1972. Certain developing countries are still 
using organochlorines nowadays because of their effectiveness against certain disease-
carrying insects and insect resistance to other insecticides 34. Even though most countries 
have not used organochlorines for the last several decades, due to extremely stable 
chemical characteristics, DDE (as a major metabolite of DDT) can currently be found in 
human serum, adipose tissue, and many foods 30, 35. 
Organophosphorus insecticides are irreversible inhibitors of cholinesterases, 
including acetyl cholinesterase, resulting in hyper-stimulation of cholinergic nerves (e.g. 
muscarinic and nicotinic acetylcholine receptor) 36. As the largest insecticide class in the 
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world in 1980s, organophosphorus insecticides occupied 71% of world insecticides 
market in 1987; however, the use of organophosphorus insecticides dropped to around 
52% in 1999 and to 13% in 2013 37-39. The use of organophosphorus insecticides was 
decreased due to their environmental persistence and mammalian toxicity, although some 
are considered as relatively less toxic to humans and less stable in the environment than 
organochlorines 27, 40.  
Carbamates, which account for 6% of global insecticides 39, have the similar 
mechanism of action with organophosphorus insecticides, but their neurotoxic effects are 
relatively more moderate than organophosphorus because the inhibition of acetyl 
cholinesterase is reversible and carbamates are known to be rapidly metabolized by 
human and animals 30, 41.  
Developed in the 1960s and 1970s, pyrethroids are structural analogs to naturally 
occurring insecticide, pyrethrin, found in Chrysanthemum flower heads. Pyrethroids can 
cause over excitation of the neuron by delaying the closing of VSSC, producing an effect 
similar to, but more pronounced than, DDT due to its better sodium channel binding 
capacity 18, 34. Generally, pyrethroid can be divided into two types; Type I and Type II. 
Type I pyrethroid (non -cyano moiety) mainly generates repetitive firing of action 
potential, which leads to the tremor syndrome (T-syndrome). Type II pyrethroids (-
cyano moiety) cause excessive membrane depolarization that leads to decreased action 
potential, which will eventually block nerve signal conduction, leading to choreoathetosis 
with salivation (CS syndrome) 42, 43. By 2013, pyrethroids accounted for approximately 
17% of the global insecticide market 39.  
Neonicotinoids are a relatively new family of insecticides with structural 
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resemblance to nicotine 27. Acting on nicotinic acetylcholine receptors, neonicotinoids 
can stimulate these receptors at low doses, while blocking these receptors at high doses, 
leading to paralysis and death 44. Their high affinity for insect nicotinic acetylcholine 
receptors, but not to vertebrate nicotinic acetylcholine receptors, contributes to their 
selective toxicological properties 45, 46. Ever since their first introduction in 1991, 
neonicotinoids have become the fastest growing class of insecticides used in protection of 
both agricultural crops and animal health, representing ~27% of the global insecticide 
market in 2013, which makes them the largest single insecticide class on the market 39, 47. 
Due to the potential link between use of neonicotinoids and the reduction of bee 
population, the European Commission has banned use of three neonicotinoids 
(imidaclorprid, thiamethoxam, and clothianidin) in 2013 48.  
 
2.2 Glucose and lipid metabolism overview 
Glucose, the most important carbohydrate as energy source, is utilized by various 
organs and tissues after being absorbed into the blood stream to form ATP through 
glycolysis and oxidative phosphorylation. On the other hand, dietary lipids such as 
triglycerides (TG) and free fatty acids (FFAs) also play critical roles in energy 
homeostasis. Fats are believed to provide even more energy per gram basis than glucose 
through β-oxidation and citric acid cycle 49. The rise and fall of blood glucose and lipids 
level generate signals to induce the secretion of a variety of hormones to maintain energy 
homeostasis by controlling the storage of excessive energy in the fed state and 
breakdown of intracellular energy source in the fasting state. Through this hormone-
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mediated mechanism, blood glucose and lipids (TG, FFAs, cholesterol etc.) are able to be 
maintained in a normal range in healthy individuals 50.  
Insulin is the central hormone regulating glucose and lipid metabolism in the fed 
state. The rise of glucose and after meal generate signals to induce the secretion of insulin 
from pancreas. Insulin promotes glucose uptake and glycogen synthesis in muscle and fat 
while inhibiting glucose production from the liver by blocking glycogenolysis and 
gluconeogenesis. Insulin also stimulates lipogenesis and protein synthesis while 
inhibiting lipolysis and protein degradation. Skeletal muscle is the major target site for 
insulin-dependent glucose disposal (up to 75%), while adipose tissue accounts for only a 
small fraction 51, 52. Insulin does not stimulate glucose uptake in liver, instead, it blocks 
glycogenolysis and gluconeogenesis while stimulating glycogen synthesis 52. Other 
tissues not normally sensitive to insulin action such as brain and pancreatic β-cells are 
also important in regulating glucose homeostasis 52-54. Thus, insulin resistance or 
deficiency can result in severe dysregulation of glucose and lipid homeostasis manifested 
by elevated fasting and postprandial glucose and lipids levels. 
2.2.1 Insulin signaling pathways  
 Insulin initiates its action by binding to insulin receptors. Insulin receptors, 
including insulin like growth factor (IGF)-I receptor and insulin receptor-related receptor 
(IRR), are tyrosine kinases 55. Insulin can increase the kinase activity of the insulin 
receptors, which subsequently phosphorylate insulin receptor substrates 56. Among them, 
insulin receptor substrate (IRS)-1 is believed to play a major role in regulating insulin 
signaling 57-59. Phosphorylated tyrosines in IRS serve as “docking sites” for proteins 
containing SH2 (Src-homology-2) domains, including the p85 regulatory subunit of 
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phosphoinositide 3-kinase (PI(3)K) and protein tyrosine phosphatase (SHP2). PI(3)K is 
critical in regulation of insulin action. The activation of PI(3)K can stimulate the 
phosphorylation of phosphoinositides to produce phosphatidylinositol-3-phosphates, 
especially phosphatidylinositol (3,4,5)-triphosphate (PIP3), which then bind to 
phosphoinositide-dependent kinase (PDK1). PDK1 belongs to the family of serine 
kinases that phosphorylates the serine/threonine kinase Akt (protein Kinase B). Akt also 
plays important role in transmission of insulin signal by controlling glucose transporter 4 
(GLUT4) translocation and glycogen synthesis via phosphorylated inhibition of glycogen 
synthase kinase-3 (GSK-3) 60. Atypical protein kinase Cs (PKCs), downstream of PI(3)K 
during insulin stimulation, are also suggested to play an important role in GLUT4 
translocation 61. 
 10 
 
Figure 2.1. Insulin signaling pathways. Akt, protein kinase B; C3G, rap guanine 
nucleotide exchange factor 1; CAP, c-Cbl-associated protein; Cbl, casitas B-lineage 
lymphoma; CrkII, proto-oncogene c-Crk II; IRS-1, insulin receptor substrate-1; GS, 
glycogen synthase; GSK-3, glycogen synthase kinase-3; PDK1, phosphoinositide-
dependent kinase-1; PI3K, phosphatidylinositol-3-kinase; PIP3, phosphatidylinositol 
(3,4,5)-trisphosphate; PKCλ/ζ, protein kinase C λ/ζ; PP1, protein phosphatase 1; PTEN, 
phosphatase and tensin homolog; PTP1β, protein tyrosine phosphtase 1β; Ser, serine; 
SHIP2, SH2 domain-containing inositol 5-phosphatase 2; SHP2, protein tyrosine 
phosphtase 2;Tyr, tyrosine.  
 
On the other hand, other intracellular signals may attenuate or block insulin 
signaling. For example, in addition to tyrosine phosphorylation described above insulin 
receptor and IRS proteins may undergo serine phosphorylation, which decrease insulin 
signaling by attenuating insulin stimulated tyrosine phosphorylation 62. Protein tyrosine 
phosphatases (PTPases) can also attenuate insulin signaling by rapid dephosphorylation 
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of insulin receptor and its substrates. Among them, protein tyrosine phosphatase 1B 
(PTP1B) are the most documented 63. Overexpression of phosphatidylinositol-3-
phosphates, such as phosphatase and tensin homologue (PTEN) and SH2 domain-
containing inositol-5-phosphtase (SHIP2), can decrease the level of PIP3, thus reduce 
insulin sensitivity 64, 65. 
In addition to PI(3)K activity, another pathway for insulin-stimulated glucose 
uptake via GLUT4 translocation have been identified 66. Cbl (casitas B-lineage 
lymphoma) is a ubiquitin ligase that can be tyrosine phosphorylated by insulin receptor. 
Cbl is usually binding with c-Cbl-associated protein (CAP), an adapter protein, to form 
Cbl-CAP complex. Upon phosphorylation, the Cbl-CAP complex can be translocated to 
the lipid raft domains in the plasma membrane escorted by protein flotillin and adapter 
molecule Crk II (also known as proto-oncogene c-Crk or p38, a protein that in humans is 
encoded by the CRK gene) 67. Crk II can also form a complex with rap guanyl 
nucleotide-exchange exchange factor 1 (C3G), which can subsequently activate G protein 
TC10 in the proximity of lipid rafts. This provides a second signal for GLUT4 
translocation in parallel with PI(3)K pathway 52, 68. 
2.2.2 Regulation of glucose metabolism in liver 
Glycogen content is tightly regulated by insulin and glucagon. Insulin stimulates 
glycogen synthesis by activating glycogen synthase through the inhibition of kinases such 
as protein kinase A (PKA) or glycogen synthase kinase 3 (GSK-3) and activating protein 
phosphatase 1 (PP1) 52, 60, 69.  
Gluconeogenesis and glycogenolysis is also tightly regulated by insulin. Insulin 
directly controls the activities of a series of enzymes by phosphorylation and 
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dephosphorylation cascades and mediate the gene expression encoding enzymes involved 
in gluconeogenesis and glycolysis 70. Insulin inhibits the transcription of enzymes 
involved in gluconeogenesis, including phosphoenolpyruvate carboxylase (PEPCK), 
fructose-1,6-bisphosphatase, and glucose-6-phosphatase, 71 while increases the 
transcription of glycolytic enzymes, including glucokinase and pyruvate kinase, and 
lipogenic enzymes, such as fatty acid synthase (FAS) and acetyl-CoA carboxylase 
(ACC). Forkhead family of transcription factors 72, peroxisome proliferator-activated 
receptor gamma coactivator 1 (PGC-1) 73 and sterol regulatory element-binding 
protein 1 (SREBP-1) 74 are suggested to control gene expression of enzymes involved in 
insulin-regulated gluconeogenesis and glycogenolysis.  
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Figure 2.2. Regulation of gluconeogenesis, glycogenolysis, glycolysis, glycogen 
synthesis and lipid synthesis in the liver. ACC, acetyl-CoA carboxylase; AMPK, AMP-
activated protein kinase; F-1,6-Pase, fructose-1,6-bisphosphatase; Fructose-6-P, fructose 
6-phosphate; FAS, fatty acid synthase; HK, hexokinase; Glucose-6-P, glucose-6-
phosphate;  G-6-Pase, glucose-6-phosphtase; Glut2, glucose transporter 2; GK, 
glucokinase; GP, glycogen phosphorylase; GS, glycogen synthase; PDH, pyruvate 
dehydrogenase; PEPCK, phosphoenolpyruvate carboxykinase; PFK, 
phosphofructokinase; PGC1α, peroxisome proliferator-activated receptor gamma 
coactivator 1-alpha; PGM, phosphoglucomutase; PK, pyruvate kinase; SREBP, sterol 
regulatory element-binding protein. 
 
2.2.3 Insulin resistance 
Insulin resistance is considered as a pathological state in which there is reduced 
responsiveness of circulating insulin 75. Insulin resistance in obesity and type 2 diabetes is 
believed to be associated with many factors in insulin signaling, including decreased 
concentration of insulin receptor and IRS, decreased tyrosine kinase activities of insulin 
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receptor and IRS, activity of PI(3)K, glucose transporter translocation, and activities of 
various intracellular enzymes 66.   
In addition, adipose tissue may also contribute to insulin resistance by elevating 
circulating FFAs, which may result in reduced glucose uptake, glycogen synthesis and 
glucose oxidation yet stimulated hepatic glucose output 76. This process is believed to be 
associated with reduction in IRS-1 and PI(3)K activities and accumulation of 
triglycerides and fatty acid-derived metabolites (e.g. diacylglycerol, fatty acyl-CoA and 
ceramides) in muscle and liver 52. A number of hormones secreted by fat cells, 
collectively called adipokines, including TNF-α, leptin, adiponectin and resistin, are also 
playing important roles in regulation of metabolism, energy expenditure and insulin 
resistance 52, 62. Activation of PKC and/or inhibitor of nuclear factor κB (IκB) kinase and 
serine phosphorylation of the insulin receptors and its substrates might be another 
important mechanism 52.  
 
2.2.4 Adipogenesis 
When there is less energy expenditure than energy intake, most of the extra 
energy is stored in adipocytes in the form of triglycerides. As a result, adipose tissue 
mass arise by either increase in adipocyte cell size, cell number or both 50. Adipocyte size 
is well correlated with the amount of stored triglycerides. It is suggested that mild obesity 
is generally associated with increases in cell size (hypertrophic obesity), while more 
severe obesity also involves increased fat cell number (hyperplastic obesity). 
Adipogenesis can be generally divided into several parts: preadipose proliferation, 
adipocytic differentiation, and lipogenesis. The molecular mechanism regulating 
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adipogenesis has been extensively studied in recent years. The key regulators have been 
identified as PPARɣ, the CCAAT-enhancer-binding proteins (C/EBP)s, and adipocyte 
determination and differentiation-dependent factor 1 (ADD1)/SREBP1 50. In addition to 
insulin, glucocorticoids, a steroid hormone secreted from adrenal gland, has also been 
suggested to play a central role in regulating adipogenesis. In fact, it has been 
demonstrated that the induction of PPARɣ gene by C/EBPβ,δ is largely dependent on the 
presence of glucocorticoid 50, 77. 
 
Figure 2.3. Regulation of adipogenesis. ADD1, adipocyte determination and 
differentiation-dependent factor 1; CEBPα, CCAAT/enhancer-binding protein alpha; 
CCAAT/enhancer-binding protein beta/delta CEBPβ/δ; PPARɣ, peroxisome proliferator-
activated receptor gamma; SREBP1c, sterol regulatory element-binding transcription 
factor 1c. 
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2.2.5 Regulation of lipogenesis and lipolysis 
The lipogenesis and lipolysis in adipocytes are well regulated by both hormone 
(e.g., insulin) and sympathetic stimulation (e.g., adrenergic) 70. In the fed state, 
adipocytes can pick up glucose and store them primarily as lipid with the help of insulin 
and lipogenic enzymes, including lipoprotein lipase, pyruvate dehydrogenase, fatty acid 
synthase, and acetyl-CoA carboxylase. Insulin can inhibit lipolysis in adipocytes 
primarily through inhibition of hormone-sensitive lipase via reduction in cAMP 
concentration and PKA activation 78, 79. 
 In the fasting state or when energy expenditure is increased, adipocytes 
breakdown triglycerides into free fatty acids and glycerol and release them into blood 
stream for fatty acid oxidation in liver, muscle and brown adipose tissue (BAT). Unlike 
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white adipose tissue, which is designed for storage of excess energy, BAT is designed for 
energy expenditure by producing heat 50.  
 
Figure 2.4. Regulation of lipogenesis and lipolysis in adipocyte. ACC, acetyl-CoA 
carboxylase; AKT, protein kinase B; AMPK, AMP-activated protein kinase; cAMP, 
cyclic adenosine monophosphate; CD36, cluster of differentiation 36;DGAT, diglyceride 
acyltransferase; FAS, fatty acid synthase; FFA, free fatty acid; Glucose-3-P, glycerol-3-
phosphate; Glut4, glucose transporter 4; IRS, insulin receptor substrate; LPL, lipoprotein 
lipase; HSL, hormone-sensitive lipase; PDE3B, phosphodiesterase 3B; PDH, pyruvate 
dehydrogenase; PDK1, phosphoinositide-dependent kinase-1; PI3K, 
phosphatidylinositol-3-kinase; PIP3, phosphatidylinositol (3,4,5)-trisphosphate; PKA, 
protein kinase A;TG, triglycerides; VLDL, very-low-density lipoprotein. 
2.3 Effects of insecticide exposure on glucose and lipid metabolisms 
2.3.1 Effects of insecticides on risk of diabetes in human 
Numerous epidemiological studies have found a potential association between 
insecticide exposure with increased risks of diabetes (summarized in Table 2.2). For this 
table, we have included elevated fasting blood glucose levels and insulin resistance as 
evidence of diabetes risk. Organochlorine and organophosphorus insecticides are the 
most studied, but few others reported on the role of pyrethroids, carbamates and 
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neonicotinoids on diabetes.  
Most studies on organochlorines linked the blood levels of organochlorines or 
their metabolites with increased risk of diabetes in humans, as these are known to be 
persistent in human tissues, particularly fatty tissues. Overall, there is strong indication 
that exposure to these insecticides leads to increased risk of diabetes. In addition, Boada 
et al. 80 reported a negative correlation between blood levels of aldrin and p,p’-DDD and 
insulin-like growth factor-1, which are also known to have implications for development 
of insulin resistance 81.  
Organophosphorus and carbamate insecticides have also been generally linked 
with increased risk of diabetes in humans, including pesticide applicators who were 
exposed to dichlorvos and trichlorfon 10. Interestingly, Saldana et al. reported that wives 
of pesticide applicators of organophosphorus insecticides (diazinon and phorate) along 
with carbamate insecticide (carbofuran) have increased risks of gestational diabetes 
mellitus, while no association was found for other organophosphorus (malathion and 
terbufos) or carbamate insecticide (carbaryl) 82. In addition, a study reported that patients 
with acute organophosphorus poisoning due to suicide attempts had hyperglycemia 83. 
Reports on the effects of pyrethroids on diabetes from human studies are rather 
limited and no human study on neonicotinoids and diabetes is available currently. One 
study reported that pyrethroid mixture increases the risk of diabetes among pesticide 
factory workers in China 84. Another study reported that exposure to pyrethroid 
insecticides (allethrin and prallethrin) increased plasma glucose levels in Indian men 85. 
Since neonicotinoids have been used in the last few decades and they are designed to be 
relatively quickly degraded in biological systems, it is more challenging to investigate the 
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exposure to neonicotinoids on human health perspectives 86. Overall, the majority of 
human studies have shown a positive association between exposure to certain type of 
insecticides and risk of diabetes.  
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Table 2.2. Effects of insecticide exposure on risk of diabetes in human 
Insecticidea Country Subject 
Risk of 
diabetesc 
Other 
comments 
Reference 
Organochlorine 
Aldrin USA Pesticide applicators ↑ 
 10 
Chlordane 
USA General population ↑ 
 87 
USA Pesticides applicators ↑ 
 10 
p,p′-DDD 
South 
Korea 
Age ≥ 40 × 
 
88 
p,p′-DDE 
Sweden Aged 50-74 years old × 
 89 
Sweden Fishermen and their wives ↑ 
 11 
USA General population ↑ 
 87 
USA Native Americans ↑ 
 2 
USA Mexican Americans ↑ 
 90 
Sweden Fishermen’s wives ↑ 
 91 
USA Non-diabetic ↑c 
 6 
Canada 
First Nation Community 
members 
↑ 
 
92 
Sweden 50-59 years old ↑ 
 93 
USA 
Great Lakes sport fish 
consumer 
↑ 
 
94 
USA General population ↑ 
 95 
USA 
African and White 
Americans 
× 
 7 
South 
Korea 
Age ≥ 40 ↑ 
 
88 
Slovakia Polluted area ↑ 
 96 
Finland 57-70 years old ↑ 
 97 
Belgium 
Hospital patients, staff and 
volunteers 
× 
 3 
USA Non-diabetic ↑d 
 8 
Sweden Age > 70 × 
 98 
Denmark General population ↑ 
 99 
Spain General population × 
 100 
Spain Hospital patients ↑ 
 101 
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Canada 
First Nations community 
members 
× 
↑ Blood DDE in 
diabetic 
individuals 
102 
Benin 18-65 years old ↑ 
 103 
Russia 8-9 years old boys ×d 
 104 
Belgium General population ↑ 
 105 
South 
Korea 
Hospital patients ↑ 
 
106 
Slovakia Polluted area ↑ 
 107 
Thailand General population ↑ 
 108 
Saudi 
Arabia 
30-50 years old ↑ 
 
109 
USA 
Great Lake Sport fish 
consumer 
↑ 
 
110 
Belgium Aged 50-65 years old ↑ only in men 111 
France Newborns × 
↓ Insulin & 
adiponectin level 
in female 
newborns 
112 
Canada Pregnant women ×e 
 113 
o,p'-DDE Denmark General population ↑ 
 99 
p,p'-DDT 
USA Mexican Americans ↑ 
 90 
USA General population ↑ 
 4 
USA Non-diabetic ×d 
 5 
USA General population ↑ 
 95 
USA 
African and White 
Americans 
× 
 7 
South 
Korea 
Age  ≥ 40 ↑ 
 
88 
Slovakia Polluted area ↑ 
 96 
USA Non-diabetic ×d 
 8 
Denmark General population ↑ 
 99 
Spain General population × 
 100 
Benin 18-65 years old ↑ 
 103 
South 
Korea 
Hospital patients ↑ 
 
106 
Saudi 
Arabia 
30-50 years old ↑ 
 
109 
o,p′-DDT 
South 
Korea 
Age  ≥ 40 ↑ 
 
88 
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Denmark General population ↑ 
 99 
Dieldrin USA General population × 
 95 
HCB 
 
Sweden 50-74 years old ↑ 
 89 
USA Native Americans ↑ 
 2 
USA Mexican Americans × 
 90 
USA 
African and White 
Americans 
× 
 7 
South 
Korea 
Age ≥ 40 ↑ 
 
88 
Slovakia Polluted area × 
↑ only 
prediabetes 
96 
USA Non-diabetic ×d  8 
Sweden Age > 70 ×  98 
Denmark General population ↑  99 
Spain General population ↑  100 
Spain Hospital patients ×  101 
Canada 
First Nations community 
members 
× ↑ Blood HCB 102 
Russia 8-9 years old boys ↑d 
 104 
Slovakia Polluted area ↑ 
 107 
South 
Korea 
> 40 years old ↑ 
 
114 
South 
Korea 
Hospital patients ↑ 
 
106 
Belgium 50-65 years old ↑ 
 111 
cis-nonachlor 
Canada 
First Nations community 
members 
↑ 
 
102 
South 
Korea 
Hospital patients ↑ 
 
106 
CB-153 
Sweden Fishermen and their wives ↑ only in men 11 
USA General population ↑ 
 87 
β-HCH 
Sweden 50-74 years old × 
 89 
USA Mexican Americans ↑ 
 90 
USA Non-diabetic ×d 
 5 
USA Non-diabetic ×c 
 6 
USA General population ↑ 
 95 
 23 
USA 
African and White 
Americans 
× 
 7 
South 
Korea 
Age  ≥ 40 ↑ 
 
88 
Slovakia Polluted area × 
↑ only 
prediabetes 
96 
Belgium 
Hospital patients, staff and 
volunteers 
↑ 
 3 
USA Non-diabetic ×d 
 8 
Denmark General population × 
 99 
Spain General population × 
 100 
Spain Hospital patients ↑ 
 101 
Canada 
First Nations community 
members 
× ↑ Blood β-HCH 102 
Benin 18-65 years old ↑ 
 103 
Saudi 
Arabia 
18-65 years old ↑ 
 
115 
Russia 8-9 years old boys ×d 
 104 
South 
Korea 
Aged > 40 years ↑ 
 
114 
South 
Korea 
Hospital patients × 
 
106 
ɣ -HCH 
 
USA 
African and White 
Americans 
× 
 7 
USA Non-diabetic ×d 
 8 
Saudi 
Arabia 
18-65 years old ↑ 
 
115 
Heptachlor USA Pesticide applicators ↑ 
 10 
Heptachlor 
epoxide (A 
metabolite of 
heptachlor) 
 
USA General population ↑ 
 95 
USA General population ↑ 
 116 
South 
Korea 
Age  ≥ 40 ↑ 
 
88 
South 
Korea 
Age > 40 ↑ 
 
114 
Mirex 
 
USA Native Americans ↓ 
 2 
USA General population × 
 95 
USA 
African and White 
Americans 
↑ 
 7 
South 
Korea 
Age  ≥ 40 ↑ 
 
88 
USA Non-diabetic  ×d 
 8 
 24 
Canada 
First Nations community 
members 
× 
↑ Blood mirex in 
diabetic 
individuals 
102 
Oxychlordane 
 
Sweden 50-74 years old × 
 89 
USA General population ↑ 
 87 
USA Mexican Americans ↑ 
 90 
USA Non-diabetic  ↑d 
 5 
USA Non-diabetic  ×c 
 6 
USA General population ↑ 
 95 
USA 
African and White 
Americans 
× 
 7 
South 
Korea 
Age  ≥ 40 ↑ 
 
88 
Finland 57-70 years old ↑ 
 97 
USA Non-diabetic  ×d 
 8 
Canada 
First Nations community 
members 
↑ 
↑ Blood 
oxychlordane in 
diabetic 
individuals 
102 
South 
Korea 
Aged > 40 years ↑ 
 
114 
Canada Pregnant women ×e 
 113 
TNC 
 
Sweden 50-74 years old × 
 89 
USA General population ↑ 
 87 
USA Mexican Americans ↑ 
 90 
USA Non-diabetic  ↑d 
 5 
USA Non-diabetic  ×c 
 6 
USA General population ↑ 
 95 
USA 
African and White 
Americans 
× 
 7 
South 
Korea 
Age  ≥ 40 ↑ 
 
88 
Finland 57-70 years old ↑ 
 97 
USA Non-diabetic  ×d 
 8 
Sweden age > 70 ↑ 
 98 
Canada 
First Nations community 
members 
↑ 
 
102 
Benin 18-65 years old ↑ 
 103 
 25 
Canada Pregnant women ×e 
 113 
Organophosphorus 
Dialkylpho-
sphate 
(Metabolites) 
France Newborns × ↑ Insulin level 112 
Dimethylpho-
sphate 
(Metabolites) 
Canada Pregnant women ↓e 
 
113 
Dimethylthio-
phosphate 
(Metabolites) 
Canada Pregnant women ↓e 
 
113 
Mixture 
Turkey Overdose patients ↑c Case report 83 
Iran Farmers ↑  117 
India A 15-year-old girl ↑c Case report 118 
Diazinon 
 
Israel Children ↑c 
 119 
USA 
Wives of pesticide 
applicators 
↑e 
 
82 
Dichlorvos USA Pesticides applicators ↑ 
 10 
Malathion 
Canada 
81-year-old mother and her 
39-year old son 
↑c Case report 120 
USA 
Wives of pesticide 
applicators 
×e 
 82 
 
Egypt Non-diabetic male famers ↑ 
 121 
Phorate USA 
Wives of pesticide 
applicators 
↑e 
 82 
 
Terbufos USA 
Wives of pesticide 
applicators 
× 
 82 
 
Trichlorfon USA Pesticides applicators ↑ 
 10 
Carbamates 
Carbaryl USA 
Wives of pesticide 
applicators 
×e 
 
82 
Carbofuran USA 
Wives of pesticide 
applicators 
↑e 
 
82 
Pyrethroids 
Allethrin India 
Mosquito repellent coils or 
mats users 
↑c 
 
85 
Permethrin USA Pesticides applicators × 
 10 
Prallethrin India 
Mosquito repellent coils or 
mats users 
↑c 
 
85 
Pyrethroid 
mixture 
China Pesticide factory workers ↑ 
 
84 
Pyrethroid 
mixture 
Bolivia Male pesticide sprayers ↑ 
 
122 
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Other insecticide 
Amitraz Turkey Overdose patients ↑c Case report 123 
Mixture of 
chlopyrifos & 
cypermethrin 
Morocco A 30-year-old man ↑c Case report 124 
aAbbreviation for insecticides: 2,2′-bis (4-chlorophenyl)-1,1-dichlorodiethylene (p,p'- DDD),  2,2′-bis (4-
chlorophenyl)-1,1-dichloroethylene (p,p'- DDE); 2,2′-bis (4-chlorophenyl)-1,1,1-trichloro-ethane (p,p'- 
DDT); Hexachlorobenzene (HCB); 2,2’,4,4’,5,5’-Hexachlorobiphenyl (CB-153); β-
Hexachlorocyclohexane (β-HCH); ɣ-Hexachlorocyclohexane (ɣ-HCH); trans-nonachlor (TNC). 
bAbbreviation: ↑, increase; ×, no association with; Gestational diabetes mellitus (GDM). Risk of diabetes 
including elevated blood glucose levelc, insulin resistanced, and gestational diabetes mellituse.  
 
2.3.2 Effects of insecticides on body weight change in human 
Compared to the large number of epidemiological studies on insecticide and 
diabetes, a relatively small number of studies reported a link between insecticide 
exposure and obesity (summarized in Table 3). Three reported positive association 
between organochlorine exposure (DDE and β-hexachlorocyclohexane) and body mass 
index (BMI) 3, 8, 9, while others found no association between organochlorine insecticide 
exposure (including DDE and β-HCH) and BMI 3, 8, 9, 89.  
 For other markers of lipid metabolism, there were no effects of organochlorines 
on high-density lipoprotein cholesterol (HDL-cholesterol), except one study reported 
negative correlation between DDE and HDL 6. Others reported that pyrethroid 
insecticides, allethrin and prallethrin, were linked with disturbed lipid metabolism by 
increasing triglycerides, phospholipids, very low-density lipoprotein cholesterol (VLDL-
C), but no effects on HDL 85.  
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Table 2.3. Effects of insecticide exposure on body weight change in human  
Insecticidea Study information Resultsb Reference 
 Country Description BMI Others  
Organochlorine 
p,p’-DDE 
Sweden  Women =  89 
USA Non-diabetic N/A = TG 6 
Belgium 
Obese and lean 
men & women 
=  3 
USA 
African and 
White 
Americans 
↑ 
 
↑ TG  
↓ HDL-C 
8 
Spain 
Women in early 
pregnancy & 
their newborn 
children 
↑ 
↑ Weight in the first 6 
months;  
↑ BMI at 14 months in 
infancy 
9 
Denmark 
General 
Population 
N/A 
↑ Lipid oxidation; 
↑FFA 
99 
Slovakia Polluted area ↑ 
↑ TG & cholesterol; ↓ 
testosterone in males 
107 
Belgium 
Aged 50-65 
years old 
↑ Only in men 111 
p,p’-DDT USA 
African and 
White 
Americans 
= 
 
= TG 
= HDL-C 
8 
HCB 
Sweden Women =  89 
USA 
African and 
White 
Americans 
= 
 
= TG 
= HDL-C 
8 
Spain 
Women in early 
pregnancy & 
their newborn 
children 
=  9 
Denmark 
General 
Population 
N/A ↑ Lipid oxidation 99 
Saudi 
Adults 
30-50 years old N/A 
↑ TG; ↓ HDL-
cholesterol 
115 
Slovakia Polluted area ↑ 
↑ TG & cholesterol; ↓ 
testosterone in males 
107 
Belgium 
Aged 50-65 
years old 
↑ Only in women 111 
β-HCH 
Sweden Women =  89 
USA Non-diabetic N/A = TG 6 
Belgium 
Obese and lean 
men & women 
↑ 
↑ Waist & 
subcutaneous 
abdominal fat mass 
3 
USA 
African and 
White 
Americans 
= 
 
= TG  
= HDL-C 
8 
Spain 
Women in early 
pregnancy & 
their newborn 
children 
=  9 
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ɣ-HCH USA 
African and 
White 
Americans 
= 
 
 = TG  
= HDL-C 
8 
Oxychlordane 
Sweden  Women =  89 
USA Non-diabetic N/A ↑ TG 6 
USA 
African and 
White 
Americans 
= 
↑ TG 
= HDL-C 
8 
TNC 
Sweden  Women =  89 
USA Non-diabetic N/A = TG 6 
USA 
African and 
White 
Americans 
= 
 
= TG 
= HDL-C 
8 
Mirex USA 
African and 
White 
Americans 
= 
 
= TG 
= HDL-C 
8 
Organophosphorus      
Malathion Egypt 
Non-diabetic 
male famers 
↑ ↑ Waist circumference  121 
Pyrethroids      
Allethrin India Men N/A 
↑ TG, phospholipids, 
lipid peroxides, & 
VLDL-C;  
↓ Cholesterol 
&glycolipids; 
= HDL-C & LDL-C 
85 
Prallethrin India Men N/A 
↑ TG, phospholipids, 
lipid peroxides, & 
VLDL-C;  
↓ Cholesterol & 
glycolipids; 
= HDL-C & LDL-C  
85 
aAbbreviation for insecticides: 2,2′-bis (4-chlorophenyl)-1,1-dichloroethylene (p,p'- DDE); 2,2′-bis (4-
chlorophenyl)-1,1,1-trichloro-ethane (p,p'- DDT); Hexachlorobenzene (HCB); β-Hexachlorocyclohexane 
(β-HCH); ɣ-Hexachlorocyclohexane (ɣ-HCH); trans-nonachlor (TNC).  
bAbbreviation for results: ↑, increase; ↓, decrease; =, no change; BMI, body mass index; GDM, gestional 
diabetes mellitus; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein 
cholesterol; N/A, not available; TG, triglyceride; VLDL-C, very low-density lipoprotein cholesterol. 
 
2.3.3 Effects of insecticides exposure on glucose and lipid metabolisms in animals 
Although different classes of insecticides have slightly different mechanisms of 
insecticidal action, many share common characteristics by acting on the nerve system. 
Common symptoms after exposure to insecticides include spasm, muscular tremors, and 
convulsions 27, 37. Overstimulation of the nervous system increases the energy demands 
and disturbs the functions of several organs, resulting in the disorder of energy 
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homeostasis that can lead to altered glucose and lipid metabolisms 125-128.  
2.3.3.1. Effects of insecticides on blood glucose level in rodents 
Studies have shown that exposure to all major types of insecticides induced 
hyperglycemia in experimental mice and/or rats (summarized in Table 2.4.). Among 
them, organochlorine and organophosphorus compounds are the most documented with 
relatively less reports on carbamates, pyrethroids, and neonicotinoids. Studies have 
demonstrated that exposure to certain organochlorines, organophosphorus, pyrethroids, 
and neonicotinoids elevated blood glucose levels, although inconsistent results have also 
been reported (Table 2.4.). This inconsistency may derive from the difference in dose and 
route of exposure, animal species, exposure duration, as well as methods to determine 
insulin resistance 129. In fact, others suggested that insecticide-induced hyperglycemia is 
only temporary: blood glucose concentration increased initially and then decreased with 
the possibility of reaching hypoglycemia 129-131. More importantly, our group recently 
reported that low doses of orally administrated permethrin or imidacloprid (levels lower 
than NOAEL) potentiate insulin resistance, only when high-fat diet was provided in mice 
132-134. These results suggest that low dose insecticide exposure should be evaluated along 
with other factors contributing to development of diabetes. 
2.3.3.2. Effects of insecticides on body weight in rodents 
Although it is known that overstimulation of the nervous system increases the 
energy demands that are potentially linked to reduced weight, a number of studies 
reported that exposure to insecticides can lead to increased body weight gain, while other 
studies found inconsistent results (summarized in Table 2.4.) 125-128. Exposures to 
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organochlorine insecticides (DDE, HCB, and ɣ-HCH) have led to increased body weight 
gain in rodents (Table 2.4.) 135-138, including a study of parental trans-generational 
exposure to DDT linked to increased obesity rate in the offspring 139. Similarly, others 
reported that perinatal exposure to DDT was linked to significant weight gain, but only in 
female offspring 140. Another study found reduced weight after dieldrin exposure 141. 
Organophosphorus insecticides have also been demonstrated to have moderate 
obesogenic effects. Chronic exposure to chlopyrifos under manifestation of cholinergic 
toxicity was reported to increase body weight in mice and rats 142, 143, including 
developmental exposure of chlorpyrifos on weight gain in male, but not female offspring 
144. Others reported reduced or no changes in weight after exposure to chlorpyrofos, 
dichlorvos, or dimethoate 145-147.  
Limited data are available for effects of pyrethroids and neonicotinoids on weight 
gain. Exposure to cypermethrin (a pyrethroid) or imidacloprid (a neonicotinoid) 
significantly decreased body weight in mice or rats 148-150, while no effects of 
deltamethrin on weight in mice was reported 151. Recently, our group reported that low 
doses of orally administrated permethrin or imidacloprid (levels of NOAEL and ADI) 
potentiate weight gain in male mice only when high-fat diet was provided 133, 134. Taken 
collectively, the effects of insecticide exposure on body weight change are rather limited 
and inconsistent, likely depending on various factors, such as dose and route of 
administration, species, sex, and treatment duration. With new reports on low doses of 
insecticides and dietary fat interaction, it is possible that effects of insecticide exposure 
will be significant, particularly for relatively long-term low-dose exposure, when 
combined with other known contributing factors of obesity.  
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Table 2.4. Effects of insecticides-induced alteration of glucose and lipid metabolism in mice and rats 
Insecticide 
Treatment 
Sexd 
Resultse 
Reference Dose 
(mg/kg a) 
Routeb Durationc BW Glucose Insulin TG Cholesterol Other comments 
Mice 
Organochlorine 
DDE 
0.4 & 2 Oral  
Daily for 5 
d, tested 
after 7, 14, 
21 & 28d 
M ↑ (2) 
↑ (2; 7 & 
21 d) 
= N/A N/A 
= Glucagon; 
= Insulin resistance; 
= pAkt Ser473/Akt (liver, 
muscle & fat); 
= Leptin & resistin 
135 
2 Oral 
Daily for 
5d, 1 wk 
rest, +13 
wk HFD or 
LFD w/o 
DDE  
M =  
↑ in HFD 
(wk 4 & 
8)  
↓ in HFD 
 
= 
 
= 
 
= Leptin & resistin; 
Muscle: 
↑ Glut4 in HFD; 
Fat: 
 = Glut4; 
Liver: 
↓ Lipogenesis in HFD; 
↑ FA oxidation in HFD;  
↑ FA uptake in HFD;  
↓ Gluconeogenesis in HFD 
152 
 
DDT 
50  Oral 
Single, 
tested after 
0-18h & 7 
d 
 M N/A 
↓ 5-7h, 
↑ Baseline 
glucose in 
GTT after 
7 d 
= (18h) N/A N/A 
↓ Glucose tolerance at 18h; 
↓ Insulin secretion from 
isolated islet of pancreas at 
18h, but not at 7d 
153 
1.7  Oral 
Daily for 
16 d 
(GND11.5-
PND5) 
 F & 
pups 
↓ in ♂ 
(PND5); 
↑ in adult 
♀ 
↓ (PND5); 
= (6 m 
post-
wean) 
↑ in ♀ w/ 
HFD; 
= (6 m 
post-
wean) 
↑ in ♀ w/ 
HFD 
↑ in ♀ w/ 
HFD; 
↑ Insulin resistance in ♀ w/ 
HFD & ♂ w/ LFD; 
↑ Fat mass in adult ♀; 
= Lipid level (during 6 m of 
post-weaning); 
= Food intake; 
= FFAs 
140 
Organophosphorus 
Chlorpyrifos 2  
Oral 
(Diet) 
8 wk  Mf ↑   ↑ ↑ = ↑ 
↑ Insulin resistance; 
↑ Food intake; 
↑ Leptin in ApoE3f 
142 
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Diazinon 
6.5  
(1/10 
LD50) 
i.p. 
5 times 
weekly for 
7 wk 
 M N/A ↑ N/A ↑ ↑ 
Tea and olive leaves extract 
prevented diazinon-
disturbed glucose and lipid 
metabolism 
154 
Carbamates 
Furadan 
0.125, 
0.25, & 
0.5  
i.p. 
Weekly for 
2,4, & 6 
wk 
M N/A N/A N/A ↑ ↑  
↑ Lipid content in serum, 
liver & kidney; 
↑ Phospholipid in serum, 
liver, & kidney; 
↓ Phospholipid in brain; 
= FFAs; 
↓ Lipase activity in liver and 
serum 
155 
Pyrethroids 
Cypermethrin 10 Oral 
Daily for 
28 d 
 M ↓ ↓ N/A ↑ 
↑; 
↑ VLDL, ↓ 
HDL 
 149 
Deltamethrin 
1 & 3  
(1/4 of 
NOAEL) 
Oral  
(Diet) 
Every 3 d 
in gestation 
& lactation 
in dams 
 F & ♂ 
pups 
= in ♂ 
pups 
N/A N/A N/A N/A 
Gene expression in fat of ♂ 
pups: 
↓ Glucose transport: Glut4 
(1) & Glut2; 
↓ Lipogenic gene (1) 
: SREBP1, ACC-1, FABP4, 
CD36, LPL & SCD-1; 
↓ Adipogenesis (1): PPARɣ 
& CEBPα  
151 
Neonicotinoids 
Imidacloprid 
5,10, &15  Oral 
Daily for 
15 d 
 M ↓ (15) N/A N/A N/A N/A 
↑ Liver & kidney weight 
(15) 
148 
0.06, 0.6 
& 6 
Oral 
Daily for 
12 wk 
M ↑ ↑ ↑ ↑ = 
↑ Leptin; = FFA; 
Fat: 
↑ cell size; ↑ CD36, 
SREBP1, TNFα;  
↓ CaMKKβ, 
pAMPKα/AMPKα, 
pACC/ACC;  
Liver: 
134 
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↑ PEPCK; ↓ CaMKKβ, 
PPARα, pAMPKα/AMPKα, 
pACC/ACC, Sirt1, PGC-1α; 
Muscle: 
↓ GLUT4; ↑ PDK4; = CPT1 
Rat 
Organochlorine 
DDT 
1 
Oral 
(Diet) 
180 d  M N/A N/A; 
↓ in 
sedentary 
rats; 
Significan
t 
interactio
n DDT × 
Exercise 
N/A 
↓ in 
sedentary 
rats; ↑ in 
exercised 
rats; 
Significant 
interaction 
DDT × 
Exercise 
= Food intake, carcass & 
liver lipids;                                       
Significant interaction DDT 
× Exercise (glucose 
tolerance) 
156 
20 Oral 
Daily for 
189 d 
 F = N/A N/A N/A N/A  138 
25 & 50 i.p. 
Daily for 6 
d (GND8-
14) 
F/M ↑ in F3 N/A N/A N/A N/A 
Gestational rats (F0) were 
treated and the third 
generation (F3) were 
observed  
139 
Dieldrin 
30 Oral 
Single, test 
after 24h 
M = N/A N/A N/A N/A 
↑ Liver glycogen & TG;  
= Liver phospholipid & 
cholesterol 
157 
2 Oral 6 m M ↓ ↑ N/A N/A =  141 
HCB 
*20 & 
100; 
40 & 200 
w/ food 
deprivatio
n; 
Oral 
(Diet) 
4 wk  F/M 
↑ ♂ (40) 
w/ food 
deprivatio
n, 
↑ in ♂ (20 
& 100) 
w/o food 
deprivatio
n 
N/A N/A N/A N/A 
= Food intake; 
↑ Liver weight w/ food 
restriction (20); 
↑ Liver hypertrophy w/ food 
deprivation (200) 
137 
 34 
ɣ-HCH 
(lindane) 
5,10,20, 
& 40 
Oral 
Daily for 
189 d; 
daily for 15 
wk 
 F  
 
↑ (20 & 
40) 
N/A N/A N/A N/A 
↑ Food intake & food 
efficiency (20 & 40); 
↑ Liver weight; 
40 caused death  
138 
Organophosphorus 
Acephate 
2.5  s.c. 
Daily for 8 
wk 
M N/A ↑ N/A N/A N/A 
↓ Liver glycogen; 
↑ Pyruvic acid and lactic 
acid in liver, heart, kidney, 
brain & blood 
158  
600 Oral 
Daily for 8 
wk 
F/M N/A N/A N/A ↓ = 
↓ Total lipids; 
Liver: 
↑ Total lipids (↓ microsome, 
= mitochondria, ↑ cytosol);  
↑ Phospholipids & total 
cholesterol (↓ microsome, ↓ 
mitochondria, & ↑ cytosol); 
↑ FFA & TG; 
159 
140 
(1/10 
LD50) 
Oral 
Single, 
tested after 
2-8h 
M N/A 
↑ at 2h 
and return 
to normal 
N/A N/A 
↓ in 
adrenal (2 
& 6 h) 
↑ Corticosterone (2 & 6 h); 
↑ Liver glycogen (6 h) 
↓ Gluconeogenesis (G6P & 
TAT) at 6 h; 
= Weights of adrenals & 
liver 
160 
Chlorpyrifos 
1  s.c. 
Daily for 4 
d 
(PND1-4), 
test in 
adulthood 
F/M =  =  
↑ in post-
prandial 
♂, = in 
fasting ♂; 
↓ in ♀ (p 
< 0.08) 
↑ in ♂  ↑ in ♂  = FFAs  147 
5 s.c. 
Daily for 4 
m 
 F 
↑ (starting 
at 2 m) 
N/A N/A N/A N/A 
↑ Perinephric fat weight; 
= Weights of heart, liver & 
gastrocnemius muscle  
143 
1, 2.5, & 
4 
Oral 
Daily for 
35 d, 
GND7-
PND21 to 
dams 
F& 
pups 
↑ in ♂ 
pups 
starting at 
PND 51 
(2.5);  
= in ♀ 
pups 
N/A N/A N/A N/A 
↑ Body volume in ♂ pups at 
PND 100; 
↓ Weight/volume ratio in ♂ 
pups at PND 100; 
↓ Leptin  
144 
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Diazinon 
 
40 (1/3 
LD50) 
i.p. 
Single, 
tested after 
2 h 
F N/A ↑ N/A N/A N/A 
↓ Brain glycogen; ↑ GP & 
PGM; = G6P; 
Atropine (cholinergic 
blocker), tolazoline (α- 
adrenergic blocker) and 
propranolol (β-adrenergic 
blocker) abolished or 
reduced diazinon-induced 
hyperglycemia & brain 
glycogenolysis 
161 
40 i.p.  
Single, 
tested after 
2 h 
F N/A 
↑; 
abolished 
by 
adrenal-
ectomy  
N/A N/A N/A 
↑ Lactic acid; 
= Pyruvic acid; 
Liver & brain: 
↓ Glycogen; 
↑ Glycogenolysis (↑ GP & 
PGM,  = G6P); 
↑ Glycolysis (↑ HK & LDH, 
brain only; = G6PD); 
↑ Gluconeogenesis (↑ F1,6D 
& PEPCK, liver only); 
Adrenalectomy abolished 
above changes 
126 
128 
(LD50) -1 
d; 
64 – 2d; 
16 – 8d; 
8 – 32 d 
Oral 
1 (single), 
2, 8 or 32 d 
M N/A N/A N/A 
↑ at 128; 
= other 
doses 
10, 15 d 
post-
treatment: 
↓ (64); 
↓ (16);  
= (4); 
↓ HDL; 
↑ LDL 
(except ↓ at 
16) 
↓ Phospholipids 162 
15, 30, & 
60 
Oral 
Single, 
tested after 
2 h 
M N/A ↑  N/A N/A N/A 
Liver: 
↑ GP & PEPCK (30 & 60) 
163 
15, 30, & 
60 (1/20, 
1/10, 1/5 
LD50) 
Oral 
Single, 
tested after 
2 h 
M N/A ↑  ↓ N/A N/A 
↑ TNF-α; all effect 
abolished by cAMP & 
cGMP PDE inhibitor 
164  
75 (1/4 
LD50) 
Oral 
Single, 
tested after 
28 d 
M N/A ↑ N/A N/A N/A ↑ Testosterone 165 
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6.5  
(1/10 
LD50) 
i.p. 
Single, 
(tested 
after 2 wk) 
Mg =  =  = ↓  
↓ (Wistar); 
= HDL  
↓ Glucose tolerance in GK; 
= Glut4 in fat 
166 
15, 30, & 
60  
i.p. 
Single, 
tested after 
1 & 18 h 
M N/A N/A 
↓ (1h); 
= (18h) 
N/A N/A 
↑ Langerhans islet GDH (1h, 
30 & 60; 18h); 
↑ Glutamate (1h; = 18 h) 
↑ C-peptide; 
↓ GDH gene expression 
(18h, 60) 
167 
Dichlorvos 
4 (1/20 
LD50), 40 
(1/2 LD50)  
Oral 
Single; 3, 
7, 14 d 
M N/A ↑ (40) N/A N/A N/A 
↓ Glucose tolerance; 
Liver:  
↑ GP & GS (40); ↓ uridine 
diphosphate glucose 
pyrophosphrylase 
168 
6  s.c. 
Daily for 8 
wk 
M ↓ ↑ N/A N/A N/A 
Brain: 
↑ GP; 
↓ Glycogen, HK, PFK, LDH 
& glucose uptake 
146 
20 
(1/4 LD50) 
N/A 
Single, 
tested after 
1 or 3 d 
M N/A N/A N/A N/A N/A 
Liver: 
↓ Glycogen & GK activity; 
↑ GK mRNA level; 
Pancreas: 
= GK activity & mRNA;  
= Insulin mRNA 
169 
Dimethoate 
150  i.p. 
15 & 30 d 
(every 
other days) 
M ↑ 
= (15 d); 
↑ (30 d) 
↑ ↑ 
= (15 d); 
↑ (30 d) 
 170 
20 & 40  
(1/20 & 
1/10 
LD50) 
Oral 
Daily for 
30 d 
M ↓ (40) ↑  N/A N/A N/A 
↑ Lipase & amylase; 
↓ Pancreas lipase & 
amylase; 
↓ Glucose tolerance; 
↑ Pancreas weight; 
= Weights of liver, kidney & 
adrenals 
145 
Isofenphos 20  Oral 
Single, 
tested after 
3-72h 
M N/A N/A N/A N/A N/A 
↑ Muscle lipid; 
↓ Sarcoplasmic esterase; 
↓ Muscle lipase (13-18h) 
171 
Malathion 
 
2000 s.c. 
Single, 
tested after 
0-6 h 
F                                                                                                                                                                                                                                                                                                         N/A ↑ N/A N/A N/A  172 
500 i.p. 
Single, 
tested after 
0-48 h 
F N/A 
↑ (first 6 
h) 
N/A N/A N/A 
↑ Liver, kidney, heart, & 
spleen glycogen (all 6-12 h, 
except liver 6-24 h); 
131 
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= Brain glycogen 
46 (1/25 
LD50) 
i.p. 15 d M N/A = N/A N/A N/A 
↑ Liver glycogen, 
Adrenaline (8 d), 
noradrenaline (8 d) & 
dopamine (4 d). 
173 
650  i.p. 
Single, 
tested after 
8 h 
M N/A ↑ N/A N/A N/A  174 
500  i.p. 
Single, 
tested after 
2 h 
F N/A ↑ N/A N/A N/A 
↑ Lactate; = pyruvate; 
Brain:  
↓ Glycogen; 
↑ GP, PGM & HK; 
= G6P & G6PD 
175 
125, 250, 
& 500  
i.p. 
Single, 
tested after 
0.5,1, & 2 
h  
F N/A N/A N/A N/A N/A 
Brain (500 except 
glycogen): 
↓ Glycogen (starting at 0.5 
h); 
↑ GP, PGM, HK & lactate; 
=G6P, G6PD, LDH & 
pyruvate; 
Adrenalectomy abolish 
these above changes; 
↓ Succinic dehydrogenase; 
Adrenal: 
↓ Ascorbic acid; 
↓ Cholesterol 
125 
5,10, & 
20 
Oral 
(Diet) 
4 wk M N/A ↑  N/A N/A N/A ↑ Liver PEPCK & GP  176 
5,10, & 
20 
Oral 
(Diet) 
4 wk M N/A 
↑ (10 & 
20) 
↑ (10 & 
20) 
N/A N/A 
Muscle: 
↑ PFK & GP (20); 
= HK 
177 
100 Oral 
Daily for 
32 d 
M =  = N/A N/A N/A 
↓ Food intake; 
Liver:  
↑ Weight, HK, & glycogen
； 
↓ GP 
129  
100  Oral 
Daily for 
32 d 
M N/A = N/A N/A N/A 
↓ Liver lipids; ↑ glycogen; 
↓ Muscle glycogen 
130 
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20  Oral 
Daily for 
28 d 
M N/A ↑ N/A N/A N/A 
Liver: 
↑ PEPCK; 
↑ Mitochondrial GP; 
Administration of Satureja 
khuzestanica essential oil 
(225 mg/kg/day) abolished 
the malathion induced effect 
178 
5,10, & 
20  
Oral 
(Diet) 
28 d  M N/A 
↑ (10 & 
20) 
↑ (10 & 
20) 
N/A N/A 
↓ Pancreas insulin secretion 
(glucose stimulated); 
= (KCl stimulated) 
128 
100 
(1/21 
LD50) 
Oral 
Single, 
tested after 
24 h 
M N/A N/A N/A N/A N/A 
↑ Liver glycogen & HK; 
↓ Liver GP; 
Caffeic acid (100 mg/kg) 
abolished these effects; 
127 
100 (1/21 
LD50) 
Oral 
Daily for 
32 d 
M N/A N/A N/A ↑ 
=; 
= HDL & 
LDL 
↓ Hypothalamic CRH 
mRNA; 
↑ iNOS; = nNOS 
179 
Parathion 0.1 & 0.2  s.c. 
Daily for 4 
d (PND1-
4) 
 F & M 
♂: ↑ 
(0.1); 
♀: ↓ (0.1 
& 0.2); 
↓ in ♀ w/ 
HFD 
(0.2); 
↑ (0.2) in 
only 
normal 
diet 
= 
↓ only ♀ 
in the 
fasted 
state  
↑ in ♂ w/ 
HFD;  
↓ in ♀ 
↓ Food intake in ♂ (0.2); 
↑ Food intake in ♀ (0.1); 
↓ HbA1c; 
↓ FFA in ♀ w/ normal diet; 
↓ β-hydroxybutyrate only in 
fasted ♂  
180 
Carbamates 
Carbendazim 
0.48, 
0.96, 2.4, 
& 4.8 
s.c. 
Single, 
tested after 
12 & 24h 
M N/A 
↓ after 
12h (0.48 
& 0.96) 
; ↑ after 
12h (4.8); 
↑ after 
24h 
N/A N/A 
= after 12h; 
↑ after 24h  
 181  
Pyrethroids 
Cismethrin 4 i.v. Single M N/A ↑ N/A N/A N/A 
↑ Noradrenaline, adrenaline, 
& lactate 
182 
Cypermethrin 
420 
(1/10 
LD50) 
Oral 
(Diet) 
6 m M N/A 
=; 
↑ in liver; 
N/A N/A 
↓; 
= in liver 
N/A 183 
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0.06, 
0.12, 0.3, 
& 0.6 
s.c. 
Single, 
tested after 
12 & 24h 
M N/A 
↑ after 
12h (0.3 
& 0.6); ↑ 
after 24h 
(0.06) 
N/A N/A 
↑ after 12h 
(0.06 & 
0.12); ↑ 
after 24 h 
(0.3 & 0.6) 
 181 
Decamethrin 40 i.p. Single F N/A ↑ N/A N/A N/A ↑ Lactate 184 
Deltamethrin 
1.28 
(1/100 
LD50) 
Oral 
Daily for 
30 d 
M N/A ↑ N/A ↑ 
↑; 
↑ LDL & 
VLDL; 
↓ HDL 
↑ Total lipid; 
Vitamin E attenuate adverse 
effect of deltamethrin 
185 
1.5 & 2.6 i.v. Single M N/A ↑ N/A N/A N/A 
↑ Noradrenaline, adrenaline, 
& lactate 
182 
Neonicotinoids 
Imidacloprid 
 
0, 5, 10, 
& 20  
Oral 
Daily for 
90 d 
F ↓ (20) ↑ (20) N/A = = 
↓ Food intake (20); 
↑ Weight of liver, kidney, & 
adrenal (20) 
150 
10, 30, & 
90 
Oral 
Daily from 
GND 6-
PND 21 to 
dams; 
Daily from 
PND21-
PND 42 to 
pups 
F& 
pups 
= N/A N/A N/A N/A  186 
a mg/kg BW/day unless otherwise specified (e.g. in diet), * doses are ppm in diet; NOAEL, no observed adverse effect level;  
b s.c., subcutaneous injection; i.p., intraperitoneal injection; i.v., intravenous injection 
c d, day(s); h, hour(s); m, month(s); wk, week(s); w/o, without; PND, postnatal days; GND, gestational day; 
d F, female; M, male; 
e Results are for all doses tested in each study, unless doses are indicated as numbers in parenthesis; all markers are from fasting blood samples unless otherwise specified; ↑, increase; 
↓, decrease; = no change; w/, with; ♂, male; ♀, female; N/A, not available;  
f apoE3 & C57BL/6N strain were used; gGK (Goto-Kakizaki) rats are a spontaneous animal model of non-insulin-dependent diabetes without obesity; 
Acronyms used: ACC-1, Acetyl-CoA carboxylase 1; pACC, phosphorylated ACC; pAkt, phosphorylated Akt; AMPKα, AMP-activated protein kinase alpha; pAMPKα, 
phosphorylated AMPKα; BW, body weight; cAMP, cyclic adenosine monophosphate; CaMKKβ, calcium/calmodulin-dependent protein kinase kinase β; CD36, cluster of 
differentiation 36; CEBPα, CCAAT/enhancer-binding protein α; cGMP, cyclic guanosine monophosphate; CPT1, carnitine palmitoyltransferase I; CRH, corticotropin-releasing 
hormone; FA, fatty acid; FFAs, free fatty acids; FABP4, fatty acid binding protein 4; F1,6D, fructose 1,6-bisphosphatase; GDH, glutamate dehydrogenase; GK, glucokinase; GK rat, 
Goto-Kakizaki rat; Glut2, glucose transporter 2; Glut4, glucose transporter 4; G6P, glucose-6-phosphatase; G6PD, glucose-6-phosphatase dehydrogenase; GP, glycogen 
phosphorylase; GS, glycogen synthase; GTT, glucose tolerance test; HbA1c, glycated hemoglobin; HDL, high density lipoprotein; HFD, high-fat diet; HK, hexokinase; HOMA-IR, 
homeostatic model assessment-insulin resistance; iNOS, inducible nitric oxide synthase; IL-6, interleukin 6; LDH, lactate dehydrogenase; LFD, low-fat diet; LPL, lipoprotein lipase; 
nNOS, neuronal nitric oxide synthase; PDE, phosphodiesterase inhibitor; PDK4, pyruvate dehydrogenase lipoamide kinase isozyme 4; PEPCK, phosphoenolpyruvate carboxykinase; 
 40 
PFK, phosphofructokinase; PGC-1α, peroxisome proliferator-activated receptor gamma co-activator 1; PGM, phosphoglucomutas; PK, pyruvate kinase; PPARɣ, peroxisome 
proliferator-activated receptor gamma; SCD-1, stearoyl-CoA desaturase-1; Sirt 1, NAD-dependent deacetylase sirtuin-1; SREBP1, sterol regulatory element-binding protein 1; TAT, 
tyrosine aminotransferase; TG, triglycerides; TNFα, tumor necrosis factor-α; VLDL, very low-density lipoprotein. 
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2.4 Mechanism of insecticides-induced change in glucose and lipid metabolism 
Recent studies indicate that insecticides are reported to influence various organs 
and tissues, such as endocrine organs, liver, pancreas, muscle, and adipose tissue, which 
may lead to altered glucose and lipid metabolisms 30, 187-195. A number of mechanisms 
were suggested to be influenced by insecticides; including oxidative stress and 
endoplasmic reticulum stress.  
2.4.1 Liver  
The liver, as one of the principal organs in regulation of glucose homeostasis, 
contributes to blood glucose level by maintaining a balance between storage of glucose 
via glycolysis and glycogenesis and release of glucose via glycogenolysis and 
gluconeogenesis 129, 176, 196-198. It was suggested that since insecticides are designed to 
target the nervous system, exposure to insecticides may attribute to increased liver 
glucose production to meet the increased energy demand caused by overstimulation of 
the nervous system 163. In fact, studies have demonstrated that exposure to certain 
insecticides can increase the activities of key enzymes involved in hepatic 
gluconeogenesis and glycogenolysis 126, 158, 163, 169, 176, 178, 199, 200. Organophosphorus 
insecticides were shown to increase hepatic phosphoenolpyruvate carboxykinase (a key 
enzyme for gluconeogenesis) and glycogen phosphorylase (a key enzyme for 
glycogenolysis) in both in vitro and in vivo 163, 176, 178, 200. Others, however, reported that 
insecticides increased hepatic glycogen levels by organochlorine (dieldrin) and 
organophosphorus (malathion) 131, 157. The inconsistent results obtained from different 
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studies may be explained by initially increased blood glucose level caused by 
gluconeogenesis and glycogenolysis (the maximum increase was noted at 2 h after 
administration), followed by glycogenesis, and a return to normal blood glucose level 6–
24 h after malathion treatment 129, 130. 
2.4.2 Muscle 
Muscle is tightly linked with the nervous system by neuromuscular junctions, thus 
susceptible to insecticide-induced neurotoxic effects. Previous reports have exhibited that 
exposure to malathion, an organophosphorus insecticide, decreased glycogen content in 
muscles 130, 177. In particular, Pournourmohammadi et al. reported that this was due to 
increased activities of glycogen phosphorylase and phosphofructokinase (PFK), which 
are the key enzymes regulating glycogenolysis and glycolysis, respectively 177. In 
addition, permethrin (a pyrethroid insecticide) and imidacloprid (a neonicotinoid 
insecticide) were previously shown to induce insulin resistance in C2C12 muscle cells via 
Akt signaling 24, 201.  
2.4.3 Pancreas 
Excessive stimulation of the cholinergic receptors by insecticides can result in 
disturbance of insulin and glucagon secretions, potentially due to pancreas tissue damage. 
Thus, insecticides that influence either acetylcholine level or its receptors by inhibiting 
acetylcholine esterase (organophosphorus and carbamates) or by acting as agonists to 
nicotinic acetylcholine receptors (neonicotinoids) can all potentially stimulate insulin 
release from the pancreas. Studies have found that exposure to malathion, an 
organophosphorus insecticide, resulted in elevated blood insulin levels in rats 128, 177. 
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Another study, however, found that exposure to malathion resulted in decreased glucose-
stimulated insulin secretion accompanied with patchy degenerative changes in the islets 
of Langerhans 128. Similarly, other human and animal studies also found that 
organophosphorus and carbamate insecticides can cause acute pancreatitis, which 
potentially influence insulin secretion 119, 202-212.  
2.4.4 Adipose tissue 
It is suggested that many lipophilic insecticides, such as DDE, malathion, or 
permethrin, can be easily trapped and stored in adipose tissues 128, 213, 214. In addition, in 
vitro studies using 3T3-L1 adipocytes demonstrated that DDT 215, 216, DDE 216, 217, 
imidacloprid 23, and permethrin 201, potentiated adipogenesis. Another study, however, 
found that treatment of DDE to 3T3-L1 cells did not alter adipogenesis or lipolysis, but 
increased basal free fatty acid uptake and the release of leptin, resistin, and adiponectin, 
which may be potentially linked to increased risk of obesity and type 2 diabetes 218. The 
same study also reported that oxychlordane and dieldrin (both organochlorines) increased 
basal free fatty acid uptake, but not insulin-stimulated glucose uptake in 3T3-L1 
adipocytes 218.  
2.4.5 Endocrine organs and brain 
Currently more than 101 pesticides have been listed as proven or possible 
endocrine disruptors by the Pesticide Action Network UK 191. Some of the insecticides 
disrupt the endocrine system by mimicking the action of estrogen. For example, certain 
organochlorines and carbamates were reported to inhibit androgen receptors; some 
organophosphorus insecticides were reported to increase the expression of estrogen 
 44 
responsive genes; and certain pyrethroids potentiate the action of estrogen 195. The 
endocrine disrupting activities of pesticides may potentiate the risk of obesity and type 2 
diabetes and other related diseases 219, 220.  
Along with altered glucose homeostasis, organophosphorus compounds have been 
demonstrated to elevate catecholamine levels 125, 173, 177, 221-225, which are abolished by 
adrenalectomy 125, 126. This suggests a role of adrenal glands in organophosphorus-
induced disturbance of glucose homeostasis.  
Pyrethroids were reported to inhibit progesterone action, organophosphorus 
insecticides were shown to inhibit thyroid hormone receptor 195, and exposure to an 
organophosphorus, diazinon, was previously reported to increase the serum testosterone 
levels 165. Organochlorine and carbamate insecticides showed anti-androgenic effects by 
inhibition of binding natural ligand to androgen binding receptors 191. All these hormones 
are known to influence insulin sensitivity and glucose homeostasis 226-228. It was 
suggested that insecticides were able to act as an agonist or an antagonist towards aryl 
hydrocarbon receptors and certain nuclear receptors, such as retinoic acid receptors, 
pregame X receptors, and peroxisome proliferator-activated receptors 229, 230.  
Studies have reported decreased brain glycogen content with increased activity of 
glycogen phosphorylase by organophosphorus insecticide, malathion 126, 175 and 
dichlorvos 146. It was suggested that malathion can interfere with oxygen uptake and 
promoted glycogenolysis and glycolysis in favor of anaerobic conditions to counteract 
the neurotoxic effects in rats 175. Malathion was also shown to increase lactic acid 
concentration without altering pyruvate content in the brain 125. Others reported that an 
organochlorine insecticide (dieldrin) can cause apoptosis and neural degeneration by 
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increasing acetylation of core histone H3 and H4 in neuronal cells 231. Limited studies 
reported that exposure to insecticides could affect feeding behavior by acting on the 
neural circuits 191. When low doses of imidacloprid or permethrin (at or lower than 
NOAEL) were administered in mice, no significant effects of either insecticide on food 
intake were observed 132-134.  
2.4.6 Cellular Responses 
2.4.6.1 Oxidative stress 
Oxidative stress was often suggested to be associated with insecticide-induced 
toxicity in vitro and in vivo 163, 191, 194, 232-239. It is also known that oxidative stress is 
linked with obesity and type 2 diabetes 240. Thus, many mechanistic studies have 
suggested that insecticides disrupt glucose and lipid metabolisms via oxidative stress-
mediated mechanisms, such as lipid peroxidation, mitochondrial dysfunction, inhibition 
of paraoxonase and glucose-6-phosphate dehydrogenase (G6PD), and nitrosative stress 30, 
127, 187, 191, 194, 238, 241-244.  
Glucose plays a critical role as an antioxidant against free radicals via the pentose 
phosphate pathway, in which nicotinamide adenine dinucleotide phosphate (NADP) is 
reduced to NADPH, which is subsequently used for the reduction of oxidized glutathione 
(GSH) from disulfides of GSH (GSSG) and cellular proteins 163. The increased demand 
of glucose to counteract the increased reactive oxygen species induced by insecticides has 
been suggested to cause hyperglycemia, leading to stimulated hepatic glycogenolysis and 
gluconeogenesis pathways 163. In fact, some studies found that antioxidants could 
attenuate insecticide-induced hyperglycemia 178, 185. 
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Abnormal mitochondrial respiratory chain functions can cause disturbance in 
intracellular energy homeostasis and has been involved in many diseases, including 
diabetes 245-248. Exposure to insecticides can cause muscle fasciculation, which greatly 
increase the oxygen flow into corresponding tissues and organs 178, 187, 237, 238. And this 
increased oxygen flow caused by insecticides may lead to elevated oxidative 
phosphorylation in mitochondria, which subsequently increase the production of reactive 
oxygen species as byproducts. In addition, some insecticides (rotenone or pyridaben) are 
known to disrupt mitochondrial respiratory chain reaction, mainly by inhibiting Complex 
I, II, III and V electron transport chain 249.  
Studies have demonstrated that pancreatic beta cell failure induced by insecticide 
exposure could be the result of underlying mitochondrial dysfunction in the pancreas 191, 
250, 251. It is reported that the pancreas is more susceptible to reactive oxygen species than 
other tissues because of its relative low expression of defensive enzymes against reactive 
oxygen species 252-254.  
Besides their inhibiting effect on acetylcholine esterase activity, 
organophosphorus compounds were reported to inhibit other esterases, such as the 
paraoxonase, a key enzyme involved in hydrolysis of oxons (active organophosphorus 
metabolites), which may potentially increase oxidative stress 255.  
cAMP and cGMP signaling may also play an important role in insecticide-
induced oxidative stress. Previous studies have found that increased cyclic nucleotides 
using phosphodiesterase inhibitors could protect against organophosphorus-induced lipid 
peroxidation in rat submandibular saliva 221 and liver cells 222. Similarly, another report 
supported that increased intracellular levels of cAMP and cGMP by intraperitoneal 
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administration of phosphodiesterase inhibitors could exert protective effects against 
organophosphorus-induced hyperglycemia and oxidative/nitrosative stress in Langerhans 
islets cells in rats 164. 
2.4.6.2 Endoplasmic reticulum stress 
Recent studies have found endoplasmic reticulum (ER) stress play key roles in 
development of several chronic diseases, including obesity and type 2 diabetes 256-260. 
There are a few studies reporting a correlation between several types of insecticides and 
ER stress. An organochlorine (endosulfan), carbamates (formetanate, methomyl, 
pyrimicarb), and a pyrethroid (bifenthrin) were reported to increase 78 kDa glucose-
regulated protein GRP78, also known as binding immunoglobulin protein (BiP), which is 
one of the ER stress markers in human pulmonary A549 cells 261, 262. Another pyrethroids 
insecticide, deltamethrin, was reported to induce ER stress in SK-N-AS neuroblastoma 
cells via elevation of intracellular calcium level and activation of eukaryotic translation 
initiation factor 2α (eIF2α) 42. Currently, there is no study directly determining the role of 
ER stress caused by insecticides and development of obesity and type 2 diabetes.  
2.4.6.3 Inflammatory responses  
Inflammation plays essential role in protecting cells from harmful stimuli (e.g. 
pathogens, damaged cells, or irritants) by involving immune cells and inflammatory 
cytokines [e.g., tumor necrosis factor alpha (TNFα)] 263. Recent evidence demonstrated 
that inflammation responses are also linked with the development of obesity and type 2 
diabetes 263, 264. Studies showed that exposure to insecticides disturbed glucose and lipid 
metabolism via increasing inflammatory responses in vitro and in vivo 134.  Imidacloprid, 
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a neonicotinoid insecticide, was reported to increase TNFα gene expression in fat tissue 
of male mice 134. Acute oral exposure to diazinon, an organophosphorus insecticide, was 
reported to increase TNFα level in Langerhans islets of male rats 164. Permethrin, a 
pyrethroid insecticide, increased the gene expression of TNFα in adipose tissue of male 
mice and 3T3-L1 adipocytes (Figure 6.5, Figure 4.5), which may be achieved by 
upregulation of Jun N terminal kinase (JNK) and CCAAT/enhancer binding protein 
homologous protein (CHOP) in the ER stress pathway (Section 6.4). 
2.5 Conclusion and project rationale 
The literature review has discussed that exposure to insecticides can disturb 
glucose and lipid homeostasis and potentially increase the risk of developing obesity and 
type 2 diabetes. Previous studies have largely focused on organochlorine and 
organophosphorus insecticides, with less studies on carbamates, pyrethroids and 
neonicotinoids. Furthermore, knowledge of how and when these metabolic perturbations 
may ultimately contribute to the development of obesity and related pathologies is also 
limited. Considering the currently wide use of pyrethroids and the declining use of 
organochlorines and organophosphorus, it is important to investigate the effects and 
mechanistic details of pyrethroids on alteration of glucose and lipid metabolism in vitro 
and in vivo. Permethrin is the single most widely used pyrethroid insecticide, accounting 
for ~60% of all pyrethroids 265. It was previously shown that exposure to permethrin can 
potentiate adipogenesis in 3T3-L1 adipocytes and insulin resistance in C2C12 cells in 
vitro 201; however, the effects of permethrin on glucose and lipid metabolisms in vivo and 
the mechanisms of how permethrin induce adipogenesis and insulin resistance in vitro 
have not been fully explored. The dissertation herein will evaluate the role of permethrin 
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on glucose and lipid metabolism in vivo and the molecular mechanisms of permethrin-
potentiated adipogenesis in 3T3-L1 adipocytes.  
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CHAPTER 3 
OBJECTIVES OF THE PROJECT 
The long-term goal is to develop prevention and/or treatment strategies for 
obesity and type 2 diabetes. The objective of this project is to determine the potential 
contribution of permethrin (a pyrethroid insecticide) on development of obesity and 
diabetes. The central hypothesis is exposure to permethrin will alter lipid metabolism and 
glucose homeostasis along with dietary fat, resulting in potentiated weight gain and 
impaired insulin responses. The rationale of this proposed research is: by understanding 
biochemical mechanisms by which exposure to environmental contaminants (permethrin 
in this case) may result in development of obesity and type 2 diabetes, we will be able to 
direct more efficient prevention and/or treatment strategies for these and related 
pathologies now and in the future. 
The project aims are as follows: 
Specific Aim 1: Determine the effects of permethrin and dietary fat interaction on 
development of obesity and type 2 diabetes in vivo. The hypothesis to be tested is 
permethrin will potentiate high-fat diet induced weight gain and development of insulin 
resistance in a dose-dependent manner. 
Specific Aim 2: Determine the mechanism of permethrin on impaired lipid 
metabolism in 3T3-L1 adipocytes. The hypothesis to be tested is permethrin promotes 
adipogenesis by a calcium- and ER stress-dependent mechanisms.   
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CHAPTER 4 
 
EXPOSURE TO PERMETHRIN PROMOTES HIGH-FAT-INDUCED WEIGHT 
GAIN AND INSULIN RESISTANCE IN MALE C57BL/6J MICE 
4.1 Introduction 
Permethrin [(±)-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-
dimethylcyclopropanecarboxylate] is one of the synthetic pyrethroid insecticides 
structurally based on the natural pyrethrins. First synthesized in 1973 and marketed in 
1977, permethrin is a photo-stable ester composed of the dichloro analogue of 
chrysanthemic acid and the 3-phenoxybenzyl alcohol 266. Four different stereoisomers 
can be found in the technical grade of permethrin products, and among these isomers, one 
with the [1R, cis] configuration is known to be the most potent form against insects 
(WHO 1990). In addition to the structural advancement for the enhanced environmental 
stability, permethrin exhibits excellent potency against a wide spectrum of insect pests, 
while retaining a large margin of mammalian safety 14-16. 
The action of permethrin on its molecular targets has been extensively studied and 
well-reviewed previously 18, 267, 268. Briefly, permethrin elicits a rapid functional 
disruption in the neuromuscular system by membrane depolarization. One of the 
important major target sites is located on the voltage sensitive sodium channel (VSSC) 
alpha-subunit, a pore forming transmembrane protein that consists of four homologous 
domains (I-IV) 17, 18. Permethrin is known to slow the inactivation of VSSCs and 
produces the prolonged tail currents upon repolarization of the cell membrane under 
voltage-clamp electrophysiological recording conditions 267, 269, 270. 
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Permethrin in mammals can be quickly biotransformed by ester cleavage and 
oxidation reactions and almost completely eliminated via urinary and fecal excretions 
within 12 days 16. Environmental fate of permethrin varies depending on the 
environmental conditions. A half-life of permethrin in soil under aerobic conditions has 
been estimated to be 28 days or less under laboratory study conditions 16. In fact, 
permethrin can be degraded and disappeared from the environment rapidly (several hours 
to 58 days) by photolysis, microbial and plant bio-transformations, while very little 
movement in the soil 16.  Based on these characteristics, permethrin became the first 
pyrethroid to be used under a wide range of environmental conditions, approximately 
17% of the global insecticide market was occupied by pyrethroid products by 2013 15, 18, 
39. In the US alone, ~2.2 million lbs of permethrin have been sprayed annually to 
agricultural plots, residential areas and approximately 63% is applied to the residential 
area for public health 19. Permethrin has been formulated in pet products and veterinary 
medications to control ectoparsitic arthropod pests, such as ticks and fleas. An over-the-
counter 1% permethrin formulation for human head louse control has been available to 
treat infested school aged children 20, 21. Additionally, many biting arthropods show 
avoidance behaviors to permethrin, hence many permethrin-treated materials (e.g., 
permethrin impregnated clothing including military uniforms, pet collars, and mosquito 
nets) have been developed and used to repel blood feeding arthropods 271. The 
commercial availability of those pyrethroids suggests that human exposure to permethrin 
is unavoidable.  
Previously, permethrin was reported to promote adipogenesis and induce insulin 
resistance in cell culture models similar to other types of membrane-depolarizing 
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insecticides 23-26; however, there is a lack of in vivo study determining the effect of 
permethrin on glucose and lipid metabolisms. Thus, the purpose of this study is to 
investigate the effect of permethrin exposure on development of dietary-fat-induced 
obesity and type 2 diabetes using a mouse model.  
4.2 Materials and methods 
4.2.1 Materials  
Permethrin (98%, mixture of cis and trans isomers) was from Sigma Aldrich Co. 
(St. Louis, MO). Insulin (human recombinant) was obtained from Novo Nordisk Inc. 
(Princeton, NJ). D-glucose solution (50%) was acquired from Hospira Inc. (Lake Forest, 
IL). Triglyceride (TG), cholesterol, glucose, and Pierce BCA protein assay kits were 
purchased from Thermo Scientific (Rockford, IL). Insulin ELISA kit was from ALPCO 
(Salem, NH). Leptin ELISA kit was purchased from R&D systems (Minneapolis, MN). 
Non-esterified fatty acid (NEFA) assay kit was from Wako Diagnostics (Richmond, VA). 
Rabbit antibodies of phosphorylated adenosine monophosphate-activated protein kinase α 
(pAMPKα), adenosine monophosphate-activated protein kinase α (AMPKα), 
phosphorylated acetyl-CoA carboxylase (pACC), and acetyl-CoA carboxylase (ACC) 
were purchased from Cell Signaling Technology (Danvers, MA). Mouse antibody of β-
actin were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). 
Horseradish peroxidase-conjugated anti-rabbit or anti-mouse secondary antibodies were 
also from Cell Signaling Technology (Danvers, MA). High capacity cDNA reverse 
transcription kit, real time PCR primers and Taqman gene expression master mix were 
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obtained from Applied Biosystem (Carlsbad, CA). Other chemicals were either from 
Thermo Fisher Scientific (Waltham, MA) or Sigma-Aldrich (St. Louis, MO).  
4.2.2 Animals and diet 
All animal care and procedures were approved by the Institutional Animal Care 
and Use Committee of the University of Massachusetts Amherst (Protocol # 2013-0014). 
Male C57BL/6J mice at 3 week of age from the Jackson’s Laboratory (Bar Harbor, ME) 
were housed in pairs with a 12-h light-dark cycle in a temperature and humidity 
controlled room. Mice were adapted to new environment with low-fat semi-purified AIN-
93-based diet in powdered form (TD94048, Harlan Laboratories, Madison, WI) for 3 
weeks. All mice were given a baseline insulin tolerance test (ITT) in the 2nd week of 
adaptation and a baseline glucose tolerance test (GTT) in the 3rd week of the adaptation 
period. Then, animals were randomly divided into two dietary groups: low-fat (4 w/w % 
fat) and high-fat diet groups (20 w/w % fat, TD07518, Harlan Laboratories, Madison, 
WI). The diet composition is shown in Table 4.1. Permethrin was first dissolved in 
soybean oil and then mixed with other ingredients. Within each dietary fat group, control 
(without permethrin) and three difference doses of permethrin-containing diet were given 
to mice for 12 weeks. Body weight and food intake were measured weekly. Permethrin 
doses used in the current study were chosen based on acceptable daily intake (ADI) of 
permethrin of 50 μg/ kg body weight (BW)/day and the chronic no observed effect level 
(NOEL) of permethrin of 5000 μg/kg body weight/day 272, 273. Permethrin concentration 
in low-fat diet were 0.43, 4.3 & 43 microgram per gram of diet to deliver 50 µg/kg 
BW/day, 500 µg/kg BW/day and 5000 µg/kg BW/day, respectively. For high-fat diet, 
actual permethrin concentration is 0.62, 6.2 & 62 microgram per gram of diet to deliver 
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50 µg/kg BW/day, 500 µg/kg BW/day and 5000 µg/kg BW/day, respectively. Estimated 
permethrin intake in low-fat diet fed animals were 58 ± 1 µg/kg BW/day, 594 ± 1 µg/kg 
BW/day and 6184 ± 151 µg/kg BW/day to deliver 50 µg/kg BW/day, 500 µg/kg BW/day 
and 5000 µg/kg BW/day, respectively. Estimated permethrin intake in high-fat diet fed 
animals were 72 ± 1 µg/kg BW/day, 610 ± 47 µg/kg BW/day and 6422 ± 133 µg/kg 
BW/day to deliver 50 µg/kg BW/day, 500 µg/kg BW/day and 5000 µg/kg BW/day, 
respectively. There were no significant differences on 3 permethrin doses delivered 
between high- vs. low-fat diets.  
After 12 weeks of permethrin treatment, mice were sacrificed by CO2 
asphyxiation after 4 h of fasting. Blood was collected after cardiac puncture and serum 
were separated by centrifugation at 3,000 g for 20 mins at 4 °C. Internal organs [heart, 
liver, kidneys, pancreas, spleen and adipose tissue including epididymal, retroperitoneal, 
mesenteric and subcutaneous fat from abdominal area] were weighed, snap-frozen by 
liquid nitrogen and kept in -80C for further analysis. A part of epididymal white adipose 
tissue was directly preserved in 10% neutralized formalin for histological analysis.  
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Table 4.1. Composition of experimental diet 
Ingredient Low-fat Diet High-fat Diet 
Casein 140 169.1 
L-cystine 1.8 2.2 
Corn starch 465.7 288.5 
Maltodextrin 155 132 
Sucrose 100 100 
Soybean oil 40 200 
Cellulose 50 50 
Mineral Mix, AIN-93M-MX (TD 94049) 35 42.8 
Vitamin Mix, AIN-93-VX (TD 94047) 10 12.4 
Choline Bitartrate 2.5 3 
tert-Butylhydroquinone (TBHQ) 0.008 0.04 
Total 1000 1000 
 
4.2.3 Determination of glucose homeostasis 
Insulin tolerance test was carried out three times (2nd week of adaptation period, 
week 5 and week 9) according to the method described previously 274. Mice were fasted 
for 4 hours before a bolus of insulin (0.75 U/kg) was injected intraperitoneally. Then, tail 
vein blood sample were obtained at 0, 15, 30, 60 and 120 minutes after insulin injection 
and tested for glucose level using a hand-held glucometer (Advocate, Pharma Supply Inc, 
Wellington, FL). The areas under the curve (AUC) were calculated using SigmaPlot 11.0 
(Systat Software, Inc., San Jose, CA). 
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Intraperitoneal glucose tolerance test (IPGTT) were conducted at the 3rd week of 
adaptation, week 6 and week 11 according to a method described by Andrikopoulos and 
colleagues but with slight modification 275. After 6 hours of fasting, a bolus of glucose 
solution (2 g/kg) was injected into the intraperitoneal cavity of each mouse. Blood 
glucose level was then measured at 0, 15, 30, 60, 120 min using a glucometer as 
described above. Blood samples at 0, 30, 60, 120 min were also obtained for insulin 
determination by lateral tail incision using a method described previously 276. 
Homeostatic model assessment-insulin resistance (HOMA-IR) was calculated using 
HOMA2 calculator provided by University of Oxford 277. 
4.2.4 Hematoxylin and eosin staining 
Epididymal adipose tissues were fixed with 10% neutralized formalin solution 
before embedding into paraffin. 5-m-thick sections were made for hematoxylin and 
eosin staining of nuclei and cytoplasma, respectively. Adipocyte size measurement was 
conducted by four individuals who were blinded to the treatment groups using ImageJ 
software (U.S. National Institutes of Health).  
4.2.5 Western blot analysis 
Immunoblot analysis was done based on a previous method 278. Briefly, 
radioimmunoprecipitation assay buffer (Thermo scientific, Rockford, IL) containing 
protease & phosphatase inhibitor cocktail (Thermo Scientific, Rockford, IL) was used to 
homogenize and extract proteins from epididymal adipose tissue and liver samples. The 
sample lysates were then centrifuged and supernatant was used for protein quantification, 
and subject to electrophoresis using sodium dodecyl sulfate-polyacrylamide gel (SDS-
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PAGE). After transferring to polyvinylidene fluoride membrane (Millipore, Bedford, 
MA), samples were incubated with primary and horseradish-conjugated secondary 
antibodies. Detection was performed using Image Station 4000MM instrument 
(Carestream Health, New Heaven, CT) by using Clarity ECL western blot substrate (Bio-
Rad, Hercules, CA). Results were analyzed by ImageJ software (U.S. National Institutes 
of Health). Protein levels were normalized with β-actin protein concentration. 
4.2.6 mRNA expression 
The liver, gastrocnemius skeletal muscle and epididymal adipose tissue were 
homogenized using TRIzol reagent and total RNA was extracted according to 
manufacturer’s protocol. Total RNA was subsequently reverse transcribed to cDNA 
using a High Capacity cDNA Reverse Transcription Kit (Applied Biosystem, Carlsbad, 
CA). TaqMan Gene Expression Assays for [Glucose transporter 4 (GLUT4, 
Mm00436615_m1), Sterol regulatory element-binding protein 1 (SREBP1, 
Mm00550338_m1), diacylglycerol O-acyltransferase 1 (DGAT1, Mm00515643_m1), 
diacylglycerol O-acyltransferase 2 (DGAT2, Mm00499536_m1), cluster of 
differentiation 36 (CD36, Mm00432403_m1), phosphoenolpyruvate carboxykinase 2 
(PEPCK, Mm00551411_m1), pyruvate dehydrogenase kinase 4 (PDK4, 
Mm01166879_m1) were performed on StepOne Plus real time PCR instrument (Applied 
Biosystems, Carlsbad, CA). The oligonucleotide primers for TNFα (NM_013693.2) were 
purchased from Eurofins MWG Operon (Huntsville, AL). Threshold values were 
analyzed by comparative CT (∆∆CT) method 279. Relative quantities of gene expression 
with real-time quantitative PCR (RT-qPCR) were calculated relative to 18S ribosomal 
RNA. 
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4.2.7 Statistical analysis  
Data were analyzed by PROC MIXED using the SAS software (Version 9.3, SAS 
Institute Inc., Cary, NC, USA). Body weight (Figure 1A) data were analyzed by two-way 
repeated measure Analysis of Variance (ANOVA) and the slice option in the Least 
Square (LS) means statement. All the other results were analyzed by two-way ANOVA 
with LS means statement. The Tukey-Kramer’s method was used for the multiple 
comparisons among the experimental groups. Letters (a, b, c, etc.) were used to present 
differences between each experimental group if there were significant interactions 
between diet and permethrin. p-values less than 0.05 were reported as statistically 
significant.  
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4.3 Results 
4.3.1 Permethrin promoted weight gain without influencing energy intake in high-
fat fed mice 
There was a significant effect of dietary fat (p < 0.0001), permethrin (p = 0.0478) 
and time (p < 0.0001) on body weight (Figure 4.1A). There was a significant three-way 
interaction (diet × permethrin × time) (p = 0.0057). Similarly, there was a significant 
effect of diet and permethrin treatment with significant interaction on body weight gain 
(Fig. 4.1B). These results suggest that permethrin promoted weight gain along with high-
fat diet. There was significant effect of diet on energy intake (low-fat diet 4677.84 ± 
56.26 kilojoules (KJ); high-fat diet 5007.39 ± 110.77 KJ), without permethrin effects or 
interaction (Fig. 4.1C). 
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Figure 4.1. Effects of permethrin treatment on body weight (A), weight gain (B) and 
energy intake (C) in male C57BL/6J mice. Mice were treated with either control or 
permethrin-containing diet [50, 500, 5000 µg/kg body weight (BW)/day] for 12 weeks in 
either low-fat or high-fat diet. (A) Blank symbols, low-fat fed mice; Filled symbols, high-
fat fed mice. Circles, control; Up-triangles, 50 µg/kg BW/day; Down-triangles 500 µg/kg 
BW/day; Squares, 5000 µg/kg BW/day. Values represent means ± S.E. (n= 5-8). Means 
with different letters are significantly different (p < 0.05). 
4.3.2 Effect of permethrin on organ weights and adipocyte size 
Organ weights (liver, pancreas, heart, kidneys, and spleen) as well as adipose 
tissue weights (epididymal, subcutaneous, mesenteric, retroperitoneal, and total adipose 
tissue) are shown in Table 4.2. There were significant effects of diet on heart (p = 
0.0001), kidney (p = 0.0007) and spleen (p = 0.0001) weights, but not liver and pancreas 
weights. Permethrin treatment had no significant effect on any of the organ weights 
(Table 4.2.). Significant diet and permethrin interactions were observed for heart and 
kidney weights.  
 There was a significant effect of diet on adipose tissue weights (Table 4.2., p < 
0.0001 for all) as well as permethrin with an exception of mesenteric adipose tissue mass 
(p < 0.05 for all) with significant interactions (p < 0.05). Specifically, permethrin 
treatment in high-fat diet significantly increased total adipose tissue mass compared to 
high-fat control (p < 0.0001 with 500 µg/kg BW/day and p = 0.0002 with 5000 µg/kg 
BW/day), while no effects of permethrin was observed in low-fat diet groups. 
Consistently, adipocyte cell sizes were significantly increased by high-fat diet (p < 
0.0001) and permethrin treatment (p = 0.046), while no diet and permethrin interaction 
was observed (Fig. 4.2B). Permethrin treatment at 500 and 5000 µg/kg BW/day 
significantly increased adipocyte size over control.  
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Figure 4.2. Effects of permethrin treatment on epididymal adipocyte size in male 
C57BL/6J mice. Mice were treated with either control or permethrin-containing diet (50, 
500, 5000 µg/kg body weight/day) for 12 weeks in either low-fat or high-fat diet. Values 
represent means ± S.E. (n= 3).  
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Table 4.2. Effects of permethrin and dietary fat on organ weights (% of body weight) in male C57BL/6J mice 
 
Low-fat  High-fat  
p-value 
 
Permethrin doses   Permethrin doses 
 
Control 50 µg/kg 500 µg/kg 5000 µg/kg  Control 50 µg/kg 500 µg/kg 5000 µg/kg  
Dietary 
fat 
Perm × 
Liver 3.90±0.12 3.60±0.23 3.95±0.23 3.59±0.17  3.51±0.18 3.33±0.21 3.67±0.13 3.64±0.07  n.s. n.s. n.s. 
Pancreas 0.43±0.04 0.50±0.05 0.46±0.01 0.44±0.02  0.54±0.05 0.45±0.04 0.36±0.03 0.38±0.03  n.s. n.s. n.s. 
Heart 0.44±0.02ab 0.49±0.03a 0.48±0.02a 0.52±0.01a  0.47±0.03ab 0.43±0.02ab 0.35±0.04b 0.35±0.02b  0.0001 n.s. 0.0025 
Kidneys 1.06±0.05abc 1.12±0.04a 1.07±0.04abc 1.11±0.01ab  1.12±0.07a 0.99±0.02abc 0.88±0.05bc 0.87±0.04c  0.0007 n.s. 0.0125 
Spleen 0.30±0.02 0.28±0.04 0.30±0.03 0.30±0.04  0.26±0.03 0.21±0.01 0.17±0.02 0.18±0.02  0.0001 n.s. n.s. 
Adipose tissue              
Epididymal 2.19±0.20c 2.19±0.17c 1.74±0.17c 1.79±0.14c  3.57±0.42b 4.57±0.27ab 5.65±0.17a 5.41±0.43a  <.0001 0.0209 0.0001 
Subcutaneous 1.36±0.24d 1.47±0.15cd 1.05±0.08d 1.05±0.17d  2.65±0.45c 3.39±0.29b 4.63±0.50ab 4.95±0.21a  <.0001 0.0093 0.0002 
Mesenteric 1.32±0.09c 1.52±0.13bc 1.22±0.06c 1.12±0.10c  2.02±0.23ab 2.17±0.14a 2.74±0.22a 2.52±0.19a  <.0001 n.s. 0.0149 
Retroperitoneal 0.59±0.08c 0.63±0.09c 0.39±0.05c 0.42±0.07c  1.09±0.12b 1.56±0.11a 2.00±0.09a 1.77±0.09a  <.0001 0.0016 <.0001 
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Total 5.45±0.57c 5.81±0.46c 4.40±0.28c 4.38±0.46c  9.34±1.13b 11.70±0.69ab 15.02±0.85a 14.65±0.62a  <.0001 0.0085 <.0001 
Mice were treated with three doses of permethrin (50, 500, & 5000 µg/kg body weight/day). Values represent means ± SE (n=5-8). 
Means with different superscripts within the same row are significantly different at P<0.05. Abbreviations: n.s., not significant; Perm, permethrin; ×, interaction 
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4.3.3 Effect of permethrin on glucose homeostasis 
To determine the role of permethrin in diet-induced insulin resistance, ITT, GTT, 
the measurement of insulin during GTT, and HOMA-IR calculations were made. There 
were no significant differences on insulin responsiveness measured by ITT, GTT, insulin 
levels, or HOMA-IR during adaptation period (Fig. 4.3A, 4.3D, 4.3G, and Fig. 4.4A, 
respectively). In weeks 5 & 9, the high-fat diet group showed significantly increased 
insulin resistance versus the low-fat fed group (p = 0.0006 and <0.0001, respectively, 
Fig. 4.3B & 4.3C). Permethrin treatment only showed significant effect on insulin 
responsiveness in week 9 (p = 0.0256) with significant interaction (p < 0.0001) (Fig. 4.3B 
& 4.3C). In the high-fat dietary groups, animals with the middle and highest dose of 
permethrin (500 µg/kg BW/day and 5000 µg/kg BW/day, respectively) showed 
significantly increased insulin resistance when compared to high-fat control and the low 
dose of permethrin at week 9 (Fig. 4.3C). However, no significant effect of permethrin 
treatment was found between low-fat groups. At weeks 6 & 11, there were significant 
effects of dietary fat (p < 0.0001for GTT (Figure 4.3E & 4.3F), with a significant 
permethrin (p = 0.0198) and interaction effect (p = 0.0061) in week 11 only. In the high-
fat dietary groups, animals with permethrin (500 µg/kg BW/day and 5000 µg/kg 
BW/day) groups showed significantly impaired glucose tolerance over high-fat control at 
week 11. When insulin levels were measured during glucose tolerance test as a marker of 
glucose homeostasis 280 (Figure 4.3G-4.3I), there was a significant effect of diet (p < 
0.0001), permethrin (p < 0.05) and interaction effects (p < 0.005) on insulin levels in both 
weeks 6 and 11 (Fig. 4.3H and 4.3I). Results of HOMA-IR are shown in Figure 4.4. Both 
dietary fat and permethrin showed significant effects in HOMA-IR at week 6, 11 & 12. 
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Significant interactions were observed at week 6, but not week 11 & 12 (Fig. 4.4B-4.4D). 
Overall, these results suggest that permethrin may cause development of insulin 
resistance along with high-fat diet. 
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Figure 4.3. Effects of permethrin treatment on insulin responsiveness in male C57BL/6J 
mice. Insulin tolerance test (ITT, Figure 4.3A-4.3C), glucose tolerance test (GTT, Figure 
4.3D-4.3F), insulin level during GTT (Figure 4.3G-4.3I). Mice were treated with either 
control or permethrin-containing diet (50, 500, 5000 µg/kg body weight/day) for 12 
weeks in each dietary group. Value represent means ± S.E. (n= 4-8). Means with different 
letters are significantly different (p < 0.05). 
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Figure 4.4. Effects of permethrin on HOMA-IR score in male C57BL/6J mice. HOMA-
IR score was calculated during adaptation period, week 6, 11 and 12 with HOMA-IR 
calculator. Mice were treated with either control or permethrin-containing diet (50, 500, 
5000 µg/kg body weight/day) for 12 weeks in each dietary group. Value represent means 
± S.E. (n= 4-8). Means with different letters are significantly different (p < 0.05). 
4.3.4 Effects of permethrin on serum markers 
Results of serum analyses are shown in Table 4.3. There were significant effects 
of diet on insulin (p < 0.0001), glucose (p = 0.0003), leptin (p < 0.0001) and cholesterol 
(p <0.0001), but not on free fatty acid or TG levels. Overall, there was a significant effect 
of permethrin treatment on insulin (p = 0.0487), glucose (p = 0.0099), leptin (p < 0.0001), 
TG (p = 0.0357) and cholesterol (p = 0.0132), but not on non-esterified fatty acids. There 
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was a significant interaction between dietary fat and permethrin treatment on glucose (p = 
0.0011), leptin (p < 0.0001) and cholesterol (p = 0.015). In high-fat dietary groups, 
permethrin treatment at 5000 µg/kg BW/day significantly increased blood level of 
glucose (p = 0.0033) and leptin (p < 0.0001) than high-fat control. Permethrin treatment 
at 500 µg/kg BW/day significantly increased blood cholesterol levels than control in 
high-fat diet groups (p = 0.0181). However, permethrin had no significant effects on any 
serum parameters tested in low-fat dietary groups.  
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Table 4.3. Effects of permethrin and dietary fat on serum parameters in male C57BL/6J mice 
 
Low-fat  High-fat  
p-value 
 Permethrin doses   Permethrin doses  
Control 50 µg/kg 500 µg/kg 5000 µg/kg  Control 50 µg/kg 500 µg/kg 5000 µg/kg  Dietary fat Perm × 
Insulin 
(ng/mL) 
0.77±0.11 0.86±0.29 1.43±0.48 1.31±0.08  2.05±0.34 3.76±0.47 2.89±0.35 3.01±0.64  <.0001 0.0487 n.s. 
Glucose 
(mg/dL) 
162.8±7.9b 159.6±10.7b 168.3±15.3b 147.6±13.0b  178.2±17.8b 150.4±14.3b 207.3±5.7ab 260.1±13.3a  0.0003 0.0099 0.0011 
Leptin 
(ng/mL) 
4.9±1.00c 6.71±1.07c 3.91±0.62c 3.17±0.45c  14.4±3.7b 35.54±4.41b 62.40±11.81a 62.97±5.94a  <.0001 <.0001 <.0001 
NEFA 
(mEq/L) 
1.20±0.08 1.21±0.14 1.46±0.11 1.10±0.02  1.06±0.09 1.20±0.14 1.13±0.08 1.28±0.04  n.s. n.s. n.s. 
TG 
(mmol/L) 
0.77±0.06 0.87±0.10 0.93±0.13 0.74±0.03  0.62±0.04 0.83±0.05 0.91±0.05 1.06±0.11  n.s. 0.0357 n.s. 
Cholesterol 
(mg/dL) 
162±9c 156±14c 169±10bc 142±13c  171±15bc 167±18bc 246±19a 229±12ab  <.0001 0.0132 0.015 
Mice were treated with three doses of permethrin (50, 500, & 5000 µg/kg body weight/day). Values represent means ± SE (n=5-8). Means with different superscripts within the 
same row are significantly different at p < 0.05. Abbreviations: n.s., not significant; TG, triglyceride; NEFA, non-esterified fatty acid. Perm, permethrin; ×, interaction. 
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4.3.5 Effects of permethrin on markers of epididymal white adipose tissue 
The AMP-activated protein kinase (AMPK) plays important role in regulating 
cellular energy metabolism as well as glucose and lipid metabolisms 281. Based on 
previous report that permethrin potentiate adipogenesis via inhibiting the activation of 
AMPK 201, we have measured AMPKα activities in epididymal adipose tissue (Fig. 4.5). 
There was a significant effect of diet on phosphorylated AMPKα and AMPKα as well as 
ratio of pAMPKα/AMPKα (p < 0.05, Fig. 4.5A-4.5C), while significant permethrin 
effects were observed on pAMPKα and pAMPKα/AMPKα without any significant 
interactions for all.  
As one of main down-stream targets of AMPK, ACC gets phosphorylated at Ser 
79 (pACC) resulting in inactivation of ACC 282, 283 (Fig. 4.5D-4.5F). There was a 
significant effect of diet (p = 0.0044) and permethrin treatment (p = 0.0215) without 
interaction on pACC level (Figure 4.5D). For ACC level, there was a significant effect of 
diet (p < 0.0001) without any effects of permethrin or interaction (Fig. 4.5E). There was a 
significant effect of permethrin (p = 0.0087) without dietary and interaction effects on 
pACC/ACC ratio (Fig. 4.5F). Calcium/calmodulin-dependent protein kinase kinase-beta 
(CaMKK) is one of upstream regulator of AMPK 284. The current results showed 
permethrin significantly decreased the protein level of CaMKK, while no effects of 
dietary fat and interaction were observed (Fig. 4.5H).  
Glucose transporter-4 (GLUT4) is the major glucose transporter responsible for 
insulin-stimulated glucose uptake expressed in both adipose tissue and muscle 285. There 
were significant effects of diet and permethrin without interaction on GLUT4 gene 
expression in adipose tissue (Fig. 4.5I). Next, we measured the expression of tumor 
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necrosis factor-α (TNFα), as it is an important inflammatory cytokine that plays key role 
in obesity induced insulin resistance in type 2 diabetes 286. Significantly higher levels of 
TNFα expression were observed by both diet and permethrin with interaction in adipose 
tissue (Fig. 4.5J). Sterol regulatory element-binding protein 1 (SREBP1) is another 
important regulator of adipogenesis 287. Permethrin significantly increased SREBP 
without effects of diet or interaction (Fig. 4.5K). We also tested CD36 (regulates fatty 
acid update) and acyl CoA: diacylglycerol acyltransferase 1 and 2 (DGAT, catalyze 
mammalian triacyglycerol synthesis and lipid droplet formation), however, there were no 
effects of diet or permethrin for these markers (data not shown)  288, 289.  
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Figure 4.5. Effects of permethrin treatment on molecular targets involved in lipid 
metabolism and inflammation in epididymal white adipose tissue in male C57BL/6J 
mice. A. Protein levels of phosphorylated AMPKα (pAMPKα); B. AMPKα; C. pAMPKα 
to AMPKα ratio; D. Phosphorylated acetyl-CoA carboxylase (pACC); E. Acetyl-CoA 
carboxylase (ACC); F. pACC to ACC ratio; and G. Representative pictures. H. 
Ca2+/calmodulin-dependent protein kinase kinase β (CaMKKβ); I, glucose transporter 
type 4 (GLUT4); J, tumor necrosis factor-α (TNFα); and K, sterol regulatory element-
binding protein (SREBP1). Mice were treated with either control or permethrin-
containing diet (50, 500, 5000 µg/kg BW/day) for 12 weeks in each dietary group. Value 
represent means ± S.E. (n= 4-5). Means with different letters are significantly different (p 
< 0.05). 
4.3.6 Effects of permethrin on the liver 
The increase in hepatic gluconeogenesis is believed to play an important role in 
the elevation of fasting blood glucose level and pathogenesis of diabetes 290, 291. 
Phosphoenolpyruvate carboxykinase (PEPCK) is the key enzyme regulating 
gluconeogenesis, as overexpression of hepatic PEPCK gene in mice lead to the 
development of non-insulin-dependent diabetes mellitus 290, 291. There was a significant 
effect of diet (p = 0.006) and permethrin (p = 0.0149) with significant interaction on 
PEPCK level (Fig. 4.6A). Permethrin treatment at 500 (p = 0.0056) and 5000 µg/kg (p = 
0.0431) significantly elevated PEPCK gene expression in the high-fat diet groups. 
However, no significant difference was found in the low-fat diet group.  
PPARα is expressed principally in liver where it play important role in regulating 
fatty acid oxidation 292. There was a significant effect of permethrin, but not diet or 
interaction, on suppressing PPARα gene expression in liver (Figure 4.6B).  
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Figure 4.6. Effects of permethrin treatment on molecular targets involved in glucose and 
lipid metabolism in the liver of male C57BL/6J mice. A. Phosphoenolpyruvate 
carboxykinase (PEPCK); B. Peroxisome proliferator-activated receptor-α (PPARα). Mice 
were treated with either control or permethrin-containing diet (50, 500, 5000 µg/kg 
BW/day) for 12 weeks in each dietary group. Value represent means ± S.E. (n= 3-5). 
Means with different letters are significantly different (p < 0.05). 
 
4.3.7 Effects of permethrin on glucose metabolism in gastrocnemius skeletal muscle 
In addition to adipose tissue, GLUT4 is expressed in the muscle, particularly 
GLUT4 level in slow muscle fibers play significant role in overall glucose metabolism 
293, 294. There was a significant effect of dietary fat (p < 0.0001) and permethrin (p = 
0.0064) without interaction on GLUT4 gene expression in gastrocnemius muscle (Fig. 
4.7A).  
Pyruvate dehydrogenase kinase (PDK) plays key role in phosphorylation and 
inactivation of pyruvate dehydrogenase complex, which controls glucose oxidation 295. 
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Insulin suppresses the PDK4 gene expression in normal state. However, this effect is 
reduced in insulin resistance state resulting in increased PDK4 gene expression 296. There 
was a significant effect of diet (p < 0.0001) and permethrin (p = 0.0226) without 
interaction on PDK4 gene expression in the muscle (Fig. 4.7B).  
 
Figure 4.7. Effects of permethrin treatment on gene expression regulating glucose 
metabolism in gastrocnemius skeletal muscle of male C57BL/6J mice. A. Glucose 
transporter type 4 (GLUT4); B. pyruvate dehydrogenase kinase 4 (PDK4). Mice were 
treated with either control or permethrin-containing diet (50, 500, 5000 µg/kg BW/day) 
for 12 weeks in each dietary group. Value represent means ± S.E. (n= 4-5).  
 
4.4 Discussion 
The current study showed that daily administration of permethrin, at dose below 
NOEL, can potentiate high-fat diet induced weight and fat mass gains as well as altered 
insulin resistance in male mice, while no effects of permethrin were observed when it 
was supplemented in low-fat diet in these animals. To our knowledge, this is the first in 
vivo study reporting the potential role of permethrin in obesity and type 2 diabetes, along 
with dietary fat interaction.  
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AMPK serves as the intracellular energy gauge and is activated when intracellular 
ATP production decreases to provide energy. In addition, AMPK can also be activated by 
Ca2+/calmodulin-dependent protein kinase kinase β (CaMKKβ) and serine/threonine 
kinase 11 (STK11), also known as liver kinase B1 (LKB1) 297. The current results 
showed that permethrin might target AMPK in adipocytes and are consistent with 
previous report that permethrin alters adipogenesis via AMPK-mediated mechanisms in 
3T3-L1 adipocytes in vitro 201. In addition, three other insecticides were reported to 
promote fat accumulation via AMPK-mediated mechanism 23, 216, 298.  
Moreover, the current study shows that permethrin, along with high-fat diet, 
worsened insulin resistance. The link between exposures to organochlorine and 
organophosphorus insecticides and increased risk of development of type 2 diabetes, in 
both humans and animals, have been reported previously 6, 24, 83, 90, 91, 95, 96, 299. In addition, 
two type I pyrethroids (allethrin and prallethrin) were previously reported to increase 
blood glucose level in male subjects 85. Another study reported male pesticide sprayers 
exposed to pyrethroid mixture have higher prevalence of developing prediabetes 122. 
Similarly, Wang et al. reported that increased the risk of diabetes among pyrethroid 
pesticide factory workers 300. Animal studies have consistently reported the link between 
exposure to pyrethroids and the disturbance of glucose homeostasis 181, 182, 184, 185. 
Exposures to cismethrin, decamehthrin, and deltamethrin were previously reported to 
increase blood glucose level in rats 182, 184, 185. Elevated level of insulin was found in the 
serum of male rat exposed to α-cypermethrin 181.  
In addition to animal studies, our group reported in vitro that permethrin reduced 
insulin-stimulated glucose uptake by decreasing the activation of AKT at Thr308 in 
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C2C12 muscle cells 201. AKT plays significant role in inducing glucose uptake by 
stimulating GLUT4 translocation to the plasma membrane 301. In this study, we did not 
measure the activity of AKT. However, we measured the gene expression of GLUT4 in 
adipose tissue and muscle. The current results indicated that permethrin treatment 
significantly decreased the gene expression of GLUT4 in both adipose tissue and muscle. 
Previously, developmental exposure to the pyrethroid insecticide deltamethrin was 
reported to decrease adipose tissue GLUT4 gene expression in male mice offspring 302. 
Neonicotinoid insecticide imidacloprid was also reported to decrease muscle GLUT4 
gene expression in mice fed with high-fat diet 134. Thus, we suspect permethrin may 
cause insulin resistance via influencing AKT signaling and GLUT4 gene expression. In 
addition, we found increased TNFα gene expression in adipose tissue by permethrin 
treatment. TNFα is one of the major factors in obesity-induced insulin resistance 286. It is 
known that TNFα can cause insulin resistance by increasing serine phosphorylation of 
insulin receptor substrate 1 (IRS-1) and inhibit insulin receptor activities 303. Thus, the 
effect of permethrin on increased TNFα gene expression may have contributed to 
permethrin’s effects on insulin resistance. Previously, it was reported that exposure to 
organophosphorus insecticide diazinon increased blood TNFα level 164. Neonicotinoid 
insecticide imidacloprid was also reported to increase TNFα gene expression in adipose 
tissue of high-fat fed mice 134. In this study, we did not measure the TNFα level in serum 
samples. Therefore, it is still not clear whether permethrin caused increased blood TNFα 
level in high-fat fed mice. In addition, increased PDK4 gene expression in muscle and 
increased PEPCK gene expression in liver by permethrin treatment would further 
contributed to altered glucose metabolism in these animals. Additional mechanistic 
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studies on insulin signaling pathway including AKT signaling and insulin-stimulated 
GLUT4 translocation will be needed to identify the exact mechanisms of permethrin on 
altered insulin responsiveness. 
With significant usage of permethrin in a number of commercial products, it is not 
surprising that permethrin residues can be frequently found in agricultural products, 
household dusts, air, and diet 214, 304-306. In fact, permethrin metabolites were frequently 
detected in adults and children urine samples 214, 304, 307. Among various exposure routes, 
it is believed that dietary exposure is the main route of exposure to permethrin 214, 304. 
Once absorbed, permethrin is rapidly metabolized by esterases and oxidases in the liver 
214, 304, 308, 309. Biological elimination half-life of permethrin ranged from 5 hours to 56 
hours when administered orally 1 mg/kg in rat 310. Due to highly lipophilic characteristic, 
however, permethrin is rather resistant to metabolism and may accumulate in adipose 
tissue 214.  
It is also important to point out that permethrin doses used in the current study are 
relatively low (lower than NOEL); ADI (50 µg/kg BW/day) 272 and NOEL (5000 µg/kg 
BW/day) 273.  Thus, the results of the current study will be significant in that even at 
exposures that are considered ‘safe’, there may be significant effects on glucose and lipid 
metabolism in animals and humans when there are additional factors present, such as diet 
or other environmental contaminants.  
Another potential mechanism is that permethrin along with its metabolites may 
serve as endocrine-disrupting agents, which contribute to lipogenesis 309, 311. The major 
permethrin metabolites include, but not limited to, 3-phenoxybenzoic acid (free and 
glucuronide and glycine conjugates), the sulfate conjugate of 4’-hydroxy-3-
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phenoxybenzoic acid, the sulfate conjugate of 2’hydroxy-3-phenoxybenzoic acid (from 
cis-permethrin only), the trans- and cis-dichlorovinyldimethylcyclopropane-carboxylic 
acids (free and glucuronide conjugates), and the 2-trans- and 2-cis-hydroxymethyl 
derivatives of each of the aforementioned trans and cis acids (free and glucuronide 
conjugates) 16, 308. Cleavage and oxidation are believed to be the two major forms of 
metabolic reaction for permethrin. Most of the metabolic reaction begins at the terminal 
aromatic ring of the phenoxybenzyl moiety as well as the germinal dimethyl group of the 
cyclopropane ring and ends by conjugation 16. It is generally accepted that cis-permethrin 
is harder to metabolize than trans-permethrin 312. McCarthy et al found that two 
permethrin metabolites, 3-phenoxybenzyl alcohol 3-(4-hydroxy-3-phenoxy) benzyl 
alcohol, and 3-phenoxybenzaldehyde possess estrogenic activity, which is about 105 less 
than that of 17β-estradiol 309. 
We have estimated doses of permethrin to be added in the diet based on average 
dietary intake and weight, although it was apparently that animals consumed higher doses 
of permethrin than originally intended (16-44% higher than intended doses, in Method 
section). However, no statistical differences were observed for doses of permethrin 
delivered to animals between two diets. Thus, any effects of permethrin observed only in 
high-fat fed animals still represent the role of dietary fat in permethrin’s biological 
function. At this moment, it is not clear how dietary fat contributed to permethrin’s effect 
on weight and fat mass gain and insulin resistance. We speculate that dietary fat caused 
metabolic changes in these animals, which may have been worsened with permethrin. 
Alternatively, since permethrin is highly lipophilic, it is likely that the absorption of 
permethrin with high-fat diet would be more efficient than that of low-fat diet. Thus, even 
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though there were no significant differences in permethrin doses administered, there may 
be dose-responses due to dietary fat content. Further investigation on the absorption 
efficacy of permethrin when delivered orally in the diet and metabolic consequence of 
permethrin are needed.  
The current results also suggest significant increase of serum cholesterol levels by 
permethrin with high-fat diet. Previously, the link between exposures (including 
developmental exposure) to organochlorine, organophosphorus, and carbamate 
insecticides and increased cholesterol level in both humans and animals were reported 107, 
140, 147, 154-156, 170, 180, 313. In addition, pyrethroid insecticides, cypermethrin and 
deltamethrin, were reported to increase blood cholesterol level in mice and rat 149, 181, 185. 
In particular, cypermethrin was reported to increase VLDL, while decreasing HDL in 
mice 149. Similarly, deltamethrin was shown to increase LDL and VLDL, while 
decreasing HDL levels in rat 185. One human study, however, reported negative 
correlation between chronic exposure to allethrin and prallethrin and blood cholesterol 
level in men 85. Therefore, exposure of pyrethroid insecticides may increase the risk of 
hypercholesterolemia. Further human studies are needed to investigate the effects of 
pyrethroid insecticides on alteration of blood cholesterol levels.  
In summary, the current study suggests the potential role of permethrin and 
dietary fat in development of excessive weight gain and insulin resistance in male mice. 
This is the first animal study determining the potential role of daily exposure to relatively 
low levels of permethrin in development of obesity and type 2 diabetes. Although it is not 
clear how permethrin elicit these effects, it is suggested that permethrin might target 
AMPK, fatty acid oxidation and insulin-sensitive glucose transporters. Based on the 
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current study, further studies are needed to identify the molecular targets of permethrin as 
well as effects of permethrin in female mice.   
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CHAPTER 5 
PERMETHRIN ALTERS GLUCOSE METABOLISM WITH HIGH-FAT DIET 
AND DECREASES VOLUNTARY ACTIVITIES IN FEMALE C57BL/6J MICE 
5.1 Introduction 
Permethrin [(±)-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2 
dimethylcyclopropanecarboxylate] is a synthetic insecticide that belongs to the pyrethroid 
family, which possesses structural resemblance to the natural pyrethrins. Developed in 
1970s, synthetic pyrethroids demonstrate significantly improved photostability than its 
natural counterparts without sacrificing its potent insecticidal activities and low acute 
mammalian toxicity 18. The use of pyrethroids has dropped slightly since 1997 27, but 
they are still the second largest insecticide class current on the market, accounting for 
16% of the global insecticides sales in 2015 47.  
In mammals, exposure to permethrin can produce syndromes of tremor and 
hyperactivities 34, 42, 43. When orally exposed, permethrin can be quickly absorbed into the 
blood and subject to hydrolysis and degradation by esterases and cytochrome P450-
dependent monooxygenases in the liver and other tissues with an elimination half-life of 
approximately 12h 18, 314, 315. Permethrin is highly lipophilic, thus less likely to 
contaminate ground water. When exposed in the environment, permethrin can be rapidly 
broken down by microorganism or sunlight 316. An experiment applying permethrin 
indoors near a window found that only 60% of permethrin remained after 20 days when it 
was exposed to daylight 316. The half-life of permethrin in soil under aerobic laboratory 
conditions was reported to be less than 28 days 16.  
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Based on these characteristics, permethrin is one of the most widely-used 
synthetic pyrethroid insecticides in agricultural, veterinary, medical and household 
setting 310. Products containing permethrin may be used on food and feed crops, on 
livestock, pets and/or on places where food is handled (e.g. restaurants) 33. Other 
applications of permethrin include in public health mosquito control programs, human 
head lice control, and/or in clothing. Thus, human exposure to permethrin is quite likely. 
Previously, some human and animal studies have found that exposure to 
pyrethroid insecticides can disturb glucose and lipid metabolisms and increase the risk of 
obesity and type 2 diabetes. 10, 84, 85, 122, 181-183, 185. Our laboratory also demonstrated that 
exposure to permethrin can increase weight gain and insulin resistance in high-fat fed 
male mice as shown in the previous chapter. However, the effects of permethrin in 
females with high-fat diet induced obesity and insulin resistance have not been 
determined. In fact, some studies suggested exposure to insecticides may have sex-
selectively influence body weights as well as glucose and lipid metabolisms 137, 140, 144, 180. 
Thus, the purpose of this study was to investigate the effects of permethrin, along with 
dietary fat, on glucose and lipid metabolisms in female C57BL/6J mice.  
5.2 Materials and methods 
5.2.1 Materials  
Permethrin (98%, mixture of cis and trans isomers) and HDL/LDL Quantitation 
kit were purchased from Sigma Aldrich Co. (St. Louis, MO). Insulin (human 
recombinant) was acquired from Novo Nordisk Inc. (Princeton, NJ). D-glucose solution 
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(50%) was obtained from Hospira Inc. (Lake Forest, IL). Glucose, cholesterol and TG kit 
were from Thermo Scientific (Rockford, IL). Insulin ELISA kit was purchased from 
Mercodia (Winston Salem, NC). Leptin ELISA kit was from R&D systems (Minneapolis, 
MN). Free fatty acid assay kit was purchased from Cell Biolabs Inc. (San Diego, CA). 
Pierce BCA protein assay kit (Thermo scientific, Rockford, IL) was used for protein 
quantification. Rabbit antibodies of phosphorylated phosphoinositide-dependent kinase 
(pPDK), phosphorylated protein kinase B at threonine 308 (pAkt Thr308) and serine 473 
(pAkt Ser473), Akt and Glucose transporter 4 (GLUT4) were purchased from Cell 
Signaling Technology (Danvers, MA). Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) antibody was from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). 
Horseradish peroxidase-conjugated anti-rabbit secondary antibody was obtained from 
Cell Signaling Technology (Danvers, MA). Other chemicals were either purchased from 
Sigma-Aldrich (St. Louis, MO) or Fisher Scientific (Waltham, MA).  
5.2.2 Animals and diet 
All animal care and procedures were approved by the Institutional Animal Care 
and Use Committee of the University of Massachusetts Amherst. Female C57BL/6J mice 
were purchased from the Jackson’s Laboratory (Bar Harbor, ME) at 3 week of age and 
were housed two mice per cage with a 12h light-dark cycle in a temperature and humidity 
controlled room. Semi-purified AIN-93-based diet from Harlan Laboratories (TD94048 
for low-fat and TD07518 for high-fat diets, Madison, WI) in powdered form were used. 
Permethrin was dissolved in soybean oil and mixed with other ingredients in diet. Diet 
and water were given to mice ad libitum throughout the experiment period except when 
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fasting was conducted prior to glucose measurement. After a week of adaptation with 
low-fat diet (4 w/w % fat), all mice were given a baseline test for insulin tolerance in the 
2nd week of adaptation and glucose tolerance test in the 3rd week of adaptation. Then, 
animals were then randomly divided into two dietary groups: low-fat diet (4 w/w % fat) 
and high-fat diet group (20 w/w % fat). Within each dietary group, control diet (without 
permethrin) and three different doses of permethrin-containing diet were given to mice 
for 12 weeks. In the low-fat diet groups, permethrin concentration in diet is 0.26, 2.6, and 
26 µg/g diet to deliver 50, 500 and 5000 µg/kg BW/day; in the high-fat diet group, 
permethrin concentration in diet is 0.36, 3.6 and 36 µg/g diet to deliver 50, 500 and 5000 
µg/kg BW/day. Body weight and food intake were measured weekly. Food intake was 
measured as the total food intake per cage. Estimated permethrin intake in low-fat diet 
fed animals were 33 ± 1 µg/kg BW/day, 334 ± 2 µg/kg BW/day and 3387 ± 93 µg/kg 
BW/day for 50 µg/kg BW/day, 500 µg/kg BW/day and 5000 µg/kg BW/day, 
respectively. Estimated permethrin intake in high-fat diet fed animals were 31 ± 2 µg/kg 
BW/day, 374 ± 11 µg/kg BW/day and 3491 ± 100 µg/kg BW/day for 50 µg/kg BW/day, 
500 µg/kg BW/day and 5000 µg/kg BW/day, respectively. There were no significant 
differences on 3 permethrin doses delivered between low- vs. high-fat diets. At the end of 
the study, mice were fasted for 4 hours and sacrificed by CO2 asphyxiation. Blood was 
immediately collected by cardiac puncture and then sera were collected by centrifugation 
at 3,000 g for 20 mins at 4 °C. Internal organs (liver, heart, pancreas, kidneys, spleen, and 
white adipose tissues including epididymal, retroperitoneal and mesenteric fat pads) were 
weighed at sacrifice and kept in -80C for further analyses. 
 88 
5.2.3 Determination of glucose homeostasis 
Insulin tolerance test (ITT) was conducted three times during the experiment 
(adaptation period, week 4, and week 10). Animals were fasted for 4 hours before test, 
tail-vein blood samples were obtained at 0, 15, 30, 60 and 120 minutes after 
intraperitoneal injection a bolus of insulin (0.75U/kg BW). Intraperitoneal glucose 
tolerance tests (GTT) were conducted in the adaptation period, at week 5 and week 11. 
Mice were fasted for 6 h prior to test. A bolus of glucose solution (2 g/kg BW) was 
injected into the intraperitoneal cavity, and blood was obtained from the tail end to 
measure glucose level at 0, 15, 30, 60, 120 min. Blood samples at 0, 30, 60, 120 min were 
also used for testing insulin level based on a method described previously 276. All blood 
glucose levels were tested by using a glucometer with test strips (Advocate, Pharma 
Supply Inc, Wellington, FL). The areas under the curve (AUC) were calculated using 
SigmaPlot 11.0 (Systat Software, Inc., San Jose, CA). HOMA-IR was calculated using 
HOMA2 calculator provided by University of Oxford 277. 
5.2.4 Voluntary movement measurement (Non-exercise physical activity test) 
Voluntary movement (non-exercise physical activity) was measured in week 1 
and week 8 by using a method described previously 278, 317. Briefly, individual mouse was 
put into a clear cage during the dark cycle(6:00 pm to 6:00 am). Diet and water 
(HydroGel, Portland, ME, USA) were provided ad libitum to mice during the 
measurement. Total travel distance (m) were recorded by an infrared camera with 
LoliTrack Quatro Video Tracking Software Version 1.0 (Loligo Systems, Tjele, 
Denmark). Data from early phase (6:00 pm to 8:00 pm) due to adaptation to new 
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environment and late phase (4:00 am to 6:00 am) due to sedentary behavior were 
excluded. Movement data from 8:00 pm to 4:00 am were used for analysis. 
5.2.5 Western blot analysis 
Immunoblot was conducted based on a method described previously 278. Briefly, 
gastrocnemius skeletal muscle was frozen in liquid nitrogen and ground using a pestle 
and mortar. Sample was lysed using radioimmunoprecipitation assay buffer containing 
protease & phosphatase inhibitor cocktail (Thermo Scientific, Rockford, IL). Sample 
lysates were then centrifuged at 12,000g for 20 min at 4 °C. Protein concentration was 
determined using Pierce BCA protein assay kit (Thermo scientific, Rockford, IL). 
Samples were then separated by sodium dodecyl sulfate−polyacrylamide gel and 
transferred to polyvinylidene fluoride membrane (Millipore, Bedford, MA). Visualization 
was achieved with an Image Station 4000MM instrument (Carestream Health, New 
Heaven, CT) by using Clarity ECL Western blot substrate (Bio-Rad, Hercules, CA) after 
incubation with primary and horseradish peroxidase-conjugated secondary antibodies. 
The band densities were analyzed using ImageJ software (U.S. National Institutes of 
Health). Protein levels were normalized to GAPDH expression. 
5.2.6 Statistical analysis 
Data were analyzed by PROC MIXED using the SAS software (Version 9.3, SAS 
Institute Inc., Cary, NC, USA). Body weight (Figure 5.1A) data were analyzed by two-
way repeated measure Analysis of Variance (ANOVA) with the slice option in the Least 
Square (LS) means statement. All the other results were analyzed by two-way ANOVA 
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with LS means statement. The Tukey-Kramer’s method was used for the multiple 
comparisons among the experimental groups. Letters (a, b, c, etc.) were used to present 
differences between each experimental group if there were significant interactions 
between dietary fat and permethrin. p-values less than 0.05 were reported as significant. 
5.3 Results 
5.3.1 Effects of permethrin on body weight, energy intake and organ weights 
Results of body weight and food intake are shown in Fig. 5.1A. Food intake was 
presented as the total energy intake over 12-week experimental period (Fig. 5.1B). There 
was a significant dietary fat effect on body weight; high-fat fed mice gained 2-fold more 
body weight than low-fat fed mice (p < 0.0001). However, no significant permethrin and 
interaction effect (dietary fat × permethrin × time) was observed. There was no 
significant difference in energy intake between high-fat and low-fat groups; 42.48-45.11 
KJ/mouse/day in low-fat vs. 42.39-44.74 KJ/mouse/day in high-fat fed animals. There 
was no effect of permethrin treatment on energy intake. 
Dietary fat significantly decreased the weight of liver, heart, spleen, and kidney, 
but not pancreas (Table 5.1). However, no significant effects of permethrin nor 
interaction effect were observed on any of the organ weights. Mice fed high-fat diet 
showed significantly higher adipose tissue weight than low-fat counterparts (1.8 fold, p < 
0.0001 for all), while no permethrin and interaction effects were observed for all adipose 
tissue weights.  
 
 91 
 
Figure 5.1. Effects of permethrin treatment on body weight (A) and energy intake (B) in 
female C57BL/6J mice. Low-fat or high-fat diet without or with permethrin [50, 500, 
5000 µg/kg body weight (BW)/day] were given to mice ad libitum for 12 weeks. (A) 
Blank symbols, low-fat fed mice; Filled symbols, high-fat fed mice. Circles, control; Up-
triangles, 50 µg/kg BW/day; Down-triangles 500 µg/kg BW/day; Squares, 5000 µg/kg 
BW/day. Values represent means ± S.E. (Figure 1A, n= 5-6; Figure 1B, n =3). Means 
with different letters are significantly different (p < 0.05).
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Table 5.1. Effects of permethrin and dietary fat on organ weights (% of body weight) in female C57BL/6J mice 
 Low-fat  High-fat  
p-value 
 Permethrin doses   Permethrin doses  
Control 50 µg/kg 500 µg/kg 5000 µg/kg  Control 50 µg/kg 500 µg/kg 5000 µg/kg  
Dietary 
fat 
Perm × 
Liver 4.15±0.19 4.18±0.08 3.84±0.16 4.05±0.10  3.42±0.23 3.44±0.22 3.63±0.13 3.62±0.07  < .0001 NS NS 
Heart 0.45±0.01 0.49±0.02 0.43±0.04 0.48±0.04  0.34±0.08 0.38±0.01 0.40±0.03 0.32±0.06  0.001 NS NS 
Spleen 0.38±0.02 0.34±0.02 0.34±0.02 0.35±0.01  0.31±0.01 0.39±0.06 0.32±0.02 0.32±0.01  0.0002 NS NS 
Kidney 1.07±0.01 1.10±0.05 0.99±0.04 1.12±0.08  0.92±0.05 0.97±0.04 0.95±0.02 0.91±0.03  0.0002 NS NS 
Pancreas 0.55±0.04 0.51±0.02 0.41±0.02 0.55±0.07  0.60±0.09 0.56±0.05 0.50±0.05 0.52±0.04  NS NS NS 
Adipose tissue              
Omental 2.20±0.29 2.63±0.20 3.18±0.21 2.43±0.31  4.62±0.51 4.36±0.43 4.59±0.43 4.65±0.42  <.0001 NS NS 
Subcutaneous 2.00±0.25 2.49±0.1 3.34±0.17 2.64±0.41  5.55±0.72 4.87±0.58 5.37±0.66 5.31±0.45  <.0001 NS NS 
Retroperitoneal 0.46±0.07 0.57±0.07 0.67±0.08 0.55±0.11  1.09±0.15 1.10±0.06 1.21±0.11 1.16±0.12  <.0001 NS NS 
Mesenteric 1.09±0.10 1.43±0.13 1.49±0.17 1.13±0.12  1.99±0.31 1.94±0.25 2.09±0.09 2.06±0.26  <.0001 NS NS 
Total 5.75±0.65 7.12±0.53 8.68±0.52 6.75±0.94  13.25±1.65 12.26±1.26 13.25±1.17 13.18±1.17  <.0001 NS NS 
Values represent means ± SE (n=5-6). Abbreviations: NS, not significant;, Perm, permethrin; ×, interaction. 
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5.3.2 Permethrin treatment significantly decreased voluntary movement (non-
exercise physical activity) along with high-fat diet 
Results of voluntary movement as travel distance change between week 1 and 
week 8 (%) are shown in Fig. 5.2. There was a significant dietary fat effect on voluntary 
activities (2.3 fold, p = 0.0186). High-fat fed mice showed significantly decreased 
voluntary activities than low-fat fed mice. There was a significant effect of permethrin (p 
= 0.0069). Permethrin treatment at 50 and 5000 µg/kg BW/day significantly decreased 
voluntary activities over control (3.7 fold and 3.5 fold, respectively, p < 0.05). No 
interaction effect of permethrin and dietary fat was found.  
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Figure 5.2. Effects of permethrin on voluntary movement (non-exercise physical activity 
test) in female C57BL/6J mice. Low-fat or high-fat diet without or with permethrin [50, 
500, 5000 µg/kg body weight (BW)/day] were given to mice ad libitum for 12 weeks. 
Voluntary movement was measured in week 1 and week 8 from 6:00 pm to 6:00 am 
during dark circle. Results are presented as travel distance change between week 1 and 
week 8. Diet and water (HydroGel, Portland, ME, USA) were provided ad libitum to 
mice during the measurement. Total travel distance (m) were recorded by an infrared 
camera with LoliTrack Quatro Video Tracking Software Version 1.0 (Loligo Systems, 
Tjele, Denmark).  Movement data from 8:00 pm to 4:00 am were used for analysis. 
Values represents means ±S.E. (n=5-6). 
5.3.3 Effects of permethrin on serum markers of glucose and lipid metabolism 
Results of serum analyses are shown in Table 5.2. Dietary fat showed significant 
effects on increasing insulin (1.6 fold), leptin (2.8 fold), cholesterol (1.1 fold) and high 
density lipoprotein cholesterol (1.2 fold) levels, but failed to show any significant effect 
on glucose, free fatty acids, triglycerides, and low-density lipoprotein cholesterol levels. 
Permethrin treatment significantly increased blood insulin (p = 0.0106) and glucose 
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levels (p = 0.0075) but failed to show any significant effect on leptin, free fatty acids, 
triglycerides, cholesterol, high-density lipoprotein and low-density lipoprotein cholesterol 
levels. There were no significant interactions between diet and permethrin on all serum 
markers tested except insulin. Permethrin treatment at 5000 µg/kg BW/day significantly 
increased insulin level than control in high-fat dietary groups (1.9 fold), but not in low-fat 
dietary groups.  
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Table 5.2. Effects of permethrin and dietary fat on serum parameters in female C57BL/6J mice 
 
Low-fat  High-fat  
p-value 
 Permethrin doses   Permethrin doses  
Control 50 µg/kg 500 µg/kg 5000 µg/kg  Control 50 µg/kg 500 µg/kg 5000 µg/kg  
Dietary 
fat 
Perm × 
Insulin 
(ng/mL) 
1.27±0.22b 1.06±0.11b 1.27±0.15b 1.11±0.09b  
1.47±0.11b 1.21±0.10b 2.04±0.34ab 2.80±0.47a 
 0.0002 0.0106 0.01 
Glucose 
(mg/dL) 
167.0±9.4 197.0±12.1 225.6±14.5 176.6±16.2  
170.8±14.4 151.4±12.5 198.0±7.3 196.1±13.7 
 NS 0.0075 NS 
Leptin 
(ng/mL) 
14.60±3.83 18.80±4.35 17.85±5.39 15.24±6.86  
48.80±8.66 36.29±7.58 57.53±9.62 48.83±9.45 
 <0.0001 NS NS 
FFA 
(mEq/mL) 
844±166 916±64 1051±170 904±160  
935±146 853±335 973±115 590±188 
 NS NS NS 
TG 
(mmol/L) 
0.43±0.07 0.49±0.10 0.67±0.06 0.43±0.12  
0.43±0.05 0.42±0.11 0.42±0.07 0.38±0.06 
 NS NS NS 
Cholesterol 
(mg/dL) 
126±5 155±11 155±10 149±19  
151±8 162±8 163±8 173±6 
 0.0234 NS NS 
HDL-C 
(mg/dL) 
109±4 117±10 113±8 116±3  
115±12 129±7 132±9 145±8 
 0.0064 NS NS 
LDL-C 
(mg/dL) 
26±2 26±4 27±3 29±7  
28±4 26±2 28±4 19±2 
 NS NS NS 
Values represent means ± SE (n=5-6). Means with different superscripts within the same row are significantly different at p < 0.05. Abbreviations: NS, not significant; FFA, 
free fatty acids; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Perm, permethrin; TG, triglycerides; ×, interaction. 
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5.3.4 Effect of permethrin on glucose homeostasis 
To measure the effects of permethrin on glucose homeostasis, insulin tolerance 
test (ITT), glucose tolerance test (GTT) with insulin measurement, and HOMA-IR 
calculations were completed. There were no significant effects of dietary fat or 
permethrin on insulin responsiveness measured by ITT, GTT, insulin level, or HOMA-IR 
during adaptation period (Fig. 5.3A, 5.3D, 5.3G, and Fig. 5.4A). In week 4 & 10, high-fat 
fed animals showed significantly increased insulin resistance compared to low-fat fed 
animals (1.2 fold for both week 4 & 10, respectively, p < 0.0001 for both week, Fig. 5.3B 
& 5.3C). Permethrin treatment significantly decreased insulin responsiveness as 
demonstrated by ITT in week 10 (1.1 fold, p = 0.0473, Fig. 5.3C). However, no 
significant interaction between dietary fat and permethrin was found in week 4 & 10. 
In week 5 & 11, there was a significant effect of dietary fat (p = 0.0008 for week 
5 and p < 0.0001 for week 11) for GTT (Fig. 5.3E & 5.3F). Permethrin showed 
significant effect on increasing glucose tolerance in week 11 (1.2 fold, p = 0.0369). 
Permethrin treatments at 5000 µg/kg BW/day significantly increased glucose tolerance 
compared to control (1.2 fold, p = 0.0383). However, no significant interaction was 
found.  
For insulin level during GTT, there was a significant effect of dietary fat on 
increasing blood insulin in week 5 & 11 (1.5 and 2.0 fold for week 5 and week 11, 
respectively, p < 0.0001 for both week 5 & 11, Fig. 5.3H & 5.3I). There was a significant 
effect of permethrin on increasing blood insulin level (1.5 fold, p = 0.0271) and 
interaction effect (p = 0.0344) in week 11 only (Fig. 5.3I). In high-fat diet, permethrin 
treatment at 5000 µg/kg BW/day significantly increased insulin level than control (2.0 
 98 
fold, p =0.0056). However, no significant effect of permethrin was observed in low-fat 
dietary groups on insulin level during GTT.  
To evaluate overall influence of permethrin on glucose homeostasis, we 
calculated HOMA-IR (Fig. 5.4). There was a significant effect of dietary fat on 
increasing HOMA-IR in week 5, 11 & 12 (1.3, 1.8, & 1.5 fold, p = 0.0096, 0.0003, & 
0.0015, respectively). There was a significant effect of permethrin (p = 0.0116) on 
increasing HOMR-IR (1.2 fold, p = 0.0268) and interaction (p = 0.0268) in week 12 only. 
Permethrin treatment at 5000 µg/kg BW/day significantly increased insulin resistance in 
high-fat dietary group compared to control (p = 0.0138). However, no significant effect 
of permethrin was found in low-fat dietary groups.  
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Figure 5.3. Effects of permethrin treatment on insulin responsiveness in female 
C57BL/6J mice. Low-fat or high-fat diet without or with permethrin [50, 500, 5000 
µg/kg body weight (BW)/day] were given to mice ad libitum for 12 weeks. Insulin 
tolerance test (ITT, Figure 3A-C), glucose tolerance test (GTT, Figure 3D-F), insulin 
level during GTT (Figure 3G-I). Values represent means ± S.E. (n= 4-6). Means with 
different letters are significantly different (p < 0.05). 
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Figure 5.4. Effects of permethrin on homeostasis model assessment - insulin resistance 
(HOMA-IR) score in female C57BL/6J mice. Low-fat or high-fat diet without or with 
permethrin [50, 500, 5000 µg/kg body weight (BW)/day] were given to mice ad libitum 
for 12 weeks. HOMA-IR score was calculated during adaptation period, week 6, 11 and 
12 with HOMA-IR calculator. Values represent means ± S.E. (n= 4-6). Means with 
different letters are significantly different (p < 0.05). 
5.3.5 Permethrin treatment significantly decreased the activation of AKT pathway 
in muscle 
Skeletal muscle plays significant role in glucose uptake, which accounts for up to 
75% of insulin-dependent glucose uptake 52. In this study, we measured several key 
regulators in insulin-stimulated glucose uptake pathway, including Akt, 
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phosphoinositide-dependent kinase (PDK1), and GLUT4. Our results showed that 
permethrin and dietary treatment showed no significant difference in changing the protein 
level of Akt and pAkt Ser473. However, permethrin treatment significantly decreased 
pAkt Thr308 (1.1 fold, p = 0.0386, Fig 5.5A) and pAkt Thr308 to Akt ratio (p = 0.0176, 
Fig. 5.5D). Phosphorylated PDK1 (pPDK1) is one of the upstream markers of Akt. 
Dietary fat showed no significant effect on pPDK1 level. Permethrin treatment had a 
significant effect of decreasing pPDK1 (p = 0.0245). There was also a significant 
interaction of dietary fat and permethrin on pPDK1 level (p = 0.0122, Fig. 5.5F). 
Permethrin treatment at 5000 µg/kg significantly decreased pPDK1 in high-fat diet 
treatment group compared to high-fat control (2.1 fold, p = 0.0242). GLUT4 is the major 
glucose transporter in skeletal muscle, which plays significant role in mediating whole 
body glucose homeostasis 294. Permethrin treatment significantly decreased GLUT4 
protein level in muscle (1.3 fold, p = 0.0078, Fig. 5.5G). However, no dietary effect and 
interaction effect was observed. Taken together, these results showed that permethrin 
may target Akt signaling pathway to induce insulin resistance.  
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Figure 5.5. Effects of permethrin treatment on molecular targets involved in insulin 
signaling pathway in gastrocnemius skeletal muscle of female C57BL/6J mice. Low-fat 
or high-fat diet without or with permethrin [50, 500, 5000 µg/kg body weight (BW)/day] 
were given to mice ad libitum for 12 weeks. A. Protein levels of phosphorylated Akt 
(pAkt) Thr308; B. pAkt Ser473; C. Akt; D. pAkt Thr308 to Akt ratio; E. pAkt Ser473 to 
Akt ratio; F. phosphorylated phosphoinositide-dependent kinase-1 (PDK1); and G. 
Glucose transporter 4 (GLUT4). Values represent means ± S.E. (n= 4-6). Means with 
different letters are significantly different (p < 0.05). 
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5.4 Discussion 
This is the first report to investigate the potential link between permethrin 
exposure and dietary fat on development of obesity and type 2 diabetes in female mice. 
The current results show that permethrin potentiated high-fat diet induced insulin 
resistance without significant induction of weight gain in C57BL/6J mice. This strain of 
mice is known to develop obesity and insulin resistance with high-fat diet 318. High-fat 
diet caused significant weight gain and worsened insulin resistance compared to low-fat 
diet fed animals without any additional caloric intake in the current study. Permethrin did 
not have any effect on weight gain in this model. However, permethrin significantly 
worsened the insulin resistance caused by high-fat diet, while no effects of insulin 
resistance were observed with permethrin in low-fat diet. The actual doses of permethrin 
consumed were similar in both low- and high-fat diets, thus we do not think the different 
effects of permethrin on insulin resistance in low vs. high-fat diet were due to different 
doses of permethrin delivered. Currently, it is not clear how permethrin worsened high-
fat diet induced insulin resistance in this model. It is possible, although, that due to highly 
lipophilic characteristics of permethrin, absorption may be more efficient with high 
dietary fat compared to that of low-fat diet. In fact, acute oral toxicity studies found that 
permethrin is much more toxic when dissolved in oil than other vehicles or its undiluted 
form 18. 
The current results showed that permethrin significantly increased blood insulin 
and glucose levels, which indicated increased risk of type 2 diabetes. Generally, the 
maximal level of permethrin was reached within 4h after oral administration and then 
cleared from plasma with a elimination half-life of approximately 12h 314. In addition, the 
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metabolic rate of permethrin in mammals also depends on different tissues and 
stereochemical configurations of permethrin. In this study, we used mixtures of cis and 
trans isomers of permethrin. Both the cis and trans isomers of permethrin were quickly 
metabolized in internal organs and tissues including the liver, kidney, muscle, spleen 
except fat, where the cis isomer was found to be much more difficult to eliminate with an 
estimated half-life of 12 days 315. Major metabolites of permethrin mainly include 3-
phenoxybenzoic acid (free and glucuronide and glycine conjugates) and the trans- and 
cis-dichlorovinyldimethylcyclopropane-carboxylic acids (free and glucuronide 
conjugates) 16. The metabolites of permethrin were found to be of lower toxicity than the 
parent compound and are readily excreted 18, 315.  
The current results showed that there was a significant effect of permethrin on 
decreasing voluntary activities of mice (p = 0.0069). It is known that pyrethroids can 
target neurons and influence physical activities in anthropods as well as mammals 319-322. 
It was previously shown that daily intraperitoneal injection of deltamethrin, at 8.3-41.5 
mg/kg body weights for 1-28 days, significantly decreased locomotive activity in mice 
321. A study reported that permethrin is more easily accumulated in the nervous system 
than plasma due to its lipophilic activity 314. The maximum amounts of permethrin in 
nervous system (e.g. cerebellum, hippocampus, caudate putamen, frontal cortex, 
hypothalamus, and sciatic nerve) were about 1.5~7.5 times higher than in plasma after 
oral administration 314.  
Our results indicated that there was a sex-dependent effect of permethrin on body 
weight. Permethrin treatment potentiated high-fat induced weight gain only in male mice 
as shown in previous chapter, but not in female mice. Previous studies on 
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organophosphorus insecticides and organochlorine insecticides also reported sex-
selective metabolic disorder caused by insecticides 137, 144, 323. Oral exposure to 
organochlorine insecticide, hexachlorobenzene, at 20 & 100 ppm in diet for four weeks, 
was reported to increase weight gain only in male rats 137. Neonatal exposure to 
organophosphorus insecticide, parathion, increased body weight gain in males, but 
decreased body weight gain in female rats at 0.1 mg/kg BW/day 180. Developmental 
exposure to organophosphorous insecticide, chlorpyrifos, initiated weight gain only in 
male offspring of rats 144. Currently, we have limited knowledge about the sex-dependent 
effects of permethrin on weight gain. It is likely that the differences in male and female 
endocrine systems might contribute to this sex-dependent effect 324.  
Development of insulin resistance is a major symptom for type 2 diabetes. Insulin 
acts via insulin receptor by auto-phosphorylation and then phosphorylates insulin 
receptor substrate (IRS) 52. The phosphorylated tyrosines in IRS serve as “docking site” 
for other proteins that has SH2 (Ser-homology-2) domains (e.g. PI(3)K) and thus regulate 
their activities or subcellular locations 52. Alternatively, IRS1 can undergo serine 
phosphorylation, which exerts inhibitory effect on insulin signaling 325. Once activated, 
IRS can activate phosphoinositide 3-kinase (PI3K), which subsequently phosphorylate 
PDK1 and activate protein kinase B (Akt). Activated Akt increases translocation of 
glucose transporter 4 (GLUT4) from cytoplasm to plasma membrane to facilitate glucose 
uptake 52. Thus, the role of Akt in insulin-stimulated glucose uptake is essential. Akt can 
be phosphorylated by PDK1 at Thr308 and by mTORC2 at Ser473 201, 326-328. 
Phosphorylation of both sites are required for Akt activation and the phosphorylation of 
Ser473 is not dependent upon phosphorylation of Thr308 or vice versa 327. Our results 
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showed that permethrin impaired Akt activation by influencing Akt phosphorylation at 
Thr308, but not Ser473 in the gastrocnemius skeletal muscle. These results indicated that 
permethrin might target upstream of PDK1 to impair glucose uptake. Previously, it was 
suggested that permethrin can significantly reduce insulin-stimulated glucose uptake in 
C2C12 muscle cells by decreasing pAkt Thr308 via PDK1, but not Ser473 201, which is 
consistent with current results. In addition, our results indicated that permethrin might 
influence glucose uptake by decreasing GLUT4 protein level in muscle, which is 
consistent with results from chapter 4.  
Pyrethroid insecticides were previously shown to disturb glucose homeostasis and 
potentially increase the risk of diabetes in human and animals 181, 182, 184, 185, 300. This study 
demonstrates that exposure to permethrin can induce high-fat diet induced insulin 
resistance without any significant influence on weight gain in female mice.  
  
 107 
 
 
CHAPTER 6 
PERMETHRIN POTENTIATES ADIPOGENESIS IN 3T3-L1 ADIPOCYTES VIA 
ALTERATION OF INTRACELLULAR CALCIUM AND ENDOPLASMIC 
RETICULUM STRESS 
6.1 Introduction 
Permethrin, a pyrethroid insecticide, was previously reported to potentiate obesity 
and insulin resistance in vivo as shown in previous chapters. In addition, our group also 
reported that permethrin can potentiate adipogenesis and insulin resistance in vitro 201. 
However, the detailed molecular mechanisms underlying this permethrin-induced 
metabolic disorder have not been fully explored. Thus, the purpose of this chapter is to 
study the potential mechanism of permethrin-potentiated adipogenesis and insulin 
resistance in 3T3-L1 adipocytes. 
The neurotoxicity of permethrin in insects as well as in mammals relies on its 
ability to bind and delay the closing of voltage sensitive sodium channels, allowing 
increased permeability of sodium ions 329. At high oral doses, permethrin can produce 
syndromes, such as aggressive sparring, increased sensitivity to external stimuli, tremor, 
and prostration 330-332. Low oral doses of permethrin can lead to dose-dependent decrease 
in locomotor activities and increase in the sensitivity of startle response to acoustic 
stimulus 322.  
In addition to sodium channel, pyrethroid insecticides are also known to influence 
the function of voltage-sensitive calcium channels, resulting in increased calcium influx 
18, 333, 334. In fact, calcium channel α1 subunits belongs to a multigene family, which is 
evolutionarily related to the voltage-sensitive sodium channel gene family 18. Previous in 
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vitro and in vivo studies in human and animals have shown that increased intracellular 
calcium is linked with augmented obesity, adipogenesis, as well as insulin resistance 335-
338. Thus, it is possible that permethrin may potentiate adipogenesis via increasing 
intracellular calcium level.   
Endoplasmic reticulum (ER) is an important organelle in eukaryotic cells, which 
is responsible for protein synthesis, folding and dispatch 259. In addition, ER also plays 
important roles for calcium storage, lipid metabolism, steroid hormone production, and 
detoxification of endogenous and exogenous compounds339. When there is an 
accumulation of unfolded or misfolded protein in the lumen of ER, the cell will activate a 
stress signaling pathway that leads to halting of protein translation, degrading unfolded 
and/or misfolded proteins, and increasing the manufacture of molecular chaperones 
involved in protein folding, which is called unfolded protein response (UPR) or ER stress 
339. Other factors that disrupt normal ER homeostasis, such as lipid accumulation, 
calcium depletion, changes in redox or energy status, etc., can also cause ER stress 339. 
The aim of UPR is to restore normal ER function; however, prolonged UPR can often 
lead to inflammation and programmed cell death 340. Recent study reported that 
pyrethroid insecticide deltamethrin can induce ER stress in nerve cells 42. As ER stress is 
also linked with obesity, adipogenesis and insulin resistance 259, 339, 341, 342, we therefore 
propose that permethrin may potentiate adipogenesis via mediating intracellular calcium 
level and ER stress in 3T3-L1 adipocytes.  
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6.2 Materials and methods 
6.2.1 Materials 
Permethrin (98%, mixture of cis and trans isomers) were purchased from Sigma 
Aldrich Co. (St. Louis, MO). 3T3-L1 preadipocytes were purchased from American Type 
Culture Collection (Manassas, VA). Dubelco’s modified Eagle’s medium (DMEM), fetal 
bovine serum (FBS), methylisobutylxanthin, dexamethasone, insulin, dimethyl sulfoxide, 
and protease inhibitor cocktail were purchased from Sigma-Aldrich (St. Louis, MO). 
Fura-2 in acetoxymethyl (AM) ester and BCA protein assay kit were purchased from 
Thermo Fisher Scientific (Agawam, MA). 
Radioimmunoprecipitation assay buffer with ethylenediaminetetraacetic acid and 
ethylene glycol tetraacetic acid was purchased from Boston Bioproducts (Ashland, MA).  
Rabbit antibodies of inositol-requiring enzyme 1 alpha (IRE1α), phosphorylated protein 
kinase R-like endoplasmic reticulum kinase (p-PERK), PERK, X-box binding protein 1s 
(XBP1s), phosphorylated eukaryotic translation initiation factor 2 alpha (p-eIF2α), eIF2α, 
calmodulin (CaM) and goat antibodies of calcium/calmodulin-dependent protein kinase 
kinase 2 (CaMKKβ) were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Rabbit 
antibodies of phosphorylated IRE1α (p-IRE1α) were obtained from Abcam (Cambridge, 
MA). Rabbit antibodies of phosphorylated insulin receptor substrate 1 Ser307 (p-IRS1 
Ser307), binding immunoglobulin protein (BiP), endoplasmic reticulum oxidoreductase 1 
alpha (Ero1-Lα) and mouse antibodies of C/EBP homologous protein (CHOP) were 
purchased from Cell Signaling Technology (Danvers, MA). Horseradish peroxidase-
conjugated anti-rabbit secondary antibody was obtained from Cell Signaling Technology 
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(Danvers, MA). Other chemicals were either purchased from Sigma-Aldrich (St. Louis, 
MO) or Fisher Scientific (Waltham, MA). High capacity cDNA reverse transcription kit, 
real time PCR primers and Taqman gene expression master mix were obtained from 
Applied Biosystem (Carlsbad, CA). Other chemicals were either from Thermo Fisher 
Scientific (Waltham, MA) or Sigma-Aldrich (St. Louis, MO).  
6.2.2 3T3-L1 cell culture 
3T3-L1 preadipocytes were cultured according to a method described previously 
23. Briefly, 3T3-L1 preadipocytes were maintained in 5% CO2 at 37˚C with DMEM 
containing 10% FBS and 1% penicillin-streptomycin until confluence (day -2). Two days 
after confluence, adipocyte differentiation was induced with a mixture of 
methylisobutylxanthin (0.5 mM), dexamethasone (1 µM), and insulin (1 µg/mL) in 
DMEM containing 10% FBS (Day 0). On day 2, this medium was replaced with DMEM 
containing 10% FBS and insulin (1 µg/mL) only. On day 4, cells were treated with 
DMEM containing 10% FBS only. On day 4 and thereafter, medium consisting of 
DMEM plus 10% FBS was subsequently replaced with fresh medium at 2 day intervals 
until harvest. Permethrin was dissolved in dimethyl sulfoxide (DMSO) prior to addition 
to culture medium to achieve various treatment concentrations (0.01, 0.1, 1, & 10 µM). 
These concentrations are based on the observation that serum and adipose tissue 
concentrations of cypermethrin administered at 2 mg/kg body weight for 10 weeks were 
in the range of 2-12 µM, while acceptable daily intake of permethrin is 0.05 mg/kg body 
weight (~60 nM) 18, 265. Overall DMSO concentration in culture medium including 
control and permethrin treatment groups were 0.02%.  
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6.2.3 Measurement of intracellular calcium  
Intracellular calcium was determined using Fura-2 acetoxymethyl (AM) ester, a 
ratiometric fluorescence Ca2+ indicator, as described previously with slight modifications 
343, 344. Briefly, 3T3-L1 cells were seeded in 96-well plate and induced to differentiation 
(day 0). Permethrin treatment was started on day 0 of differentiation until harvest. On day 
6, cells were treated with Fura-2-AM- containing 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES)-ringer buffer for 1 h at 37 °C. Then, the HEPES-
ringer buffer was removed and the cells were washed with phosphate-buffered saline 
(PBS) twice. The cells were then incubated in PBS for a further 30 minutes to allow 
complete de-esterification of intracellular acetoxymethyl esters. The intracellular Ca2+ 
level were calculated by using excitation at 340 nm and 380 nm and emission at 510 nm 
345. 
6.2.4 Western blot analysis 
Cell lysates were prepared in radioimmunoprecipitation assay (RIPA) buffer with 
ethylenediaminetetraacetic acid (EDTA) and ethylene glycol tetraacetic acid (EGTA) 
supplemented with protease inhibitor cocktail and phosphatase inhibitors. Protein 
concentrations were determined using BCA protein assay kit. Aliquots from the cell 
lysates were separated using 10% SDS-polyacrylamide gel and transferred to an 
Immobilin P membrane (Millipore, Bedford, MA). Primary antibodies were purchased 
from either Cell Signaling Technologies (Danvers, MA) or Santa Cruz Biotechnologies 
(Dallas, TX). Detection were performed using an enhanced chemiluminescence solution 
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(GE Healthcare, Piscataway, NJ) with an Image Station 4000MM (Carestream Health, 
New Haven, CT). Blot image and results were quantified using Image J software. 
6.2.5 Real time PCR analysis 
 Cells were harvested with Trizol reagent to extract total RNA under RNase free 
condition. Then total RNA was reverse transcribed to cDNA using high-capacity reverse 
transcription kit (Applied Biosystems, Carlsbad, CA). mRNA level of tumor necrosis 
factor alpha (TNFα, Mm00443258_m1), calmodulin (Mm01336281_g1), 
calcium/calmodulin dependent protein kinase kinase 2 (CaMKKβ, Mm00520236_m1) 
were analyzed by performing Taqman probe-based gene expression analysis (Applied 
Biosystems, Carlsbad, CA). 18s rRNA (Mm03928990_g1) was used as an internal 
standard.  
6.2.6 Statistical analysis 
Data were expressed as mean ± S.E. and analyzed with SAS program by one-way 
ANOVA with Tukey’s range test (SAS 9.3, Cary, NC). Significance of differences was 
defined at the P < 0.05 level. 
6.3 Results 
6.3.1 Permethrin treatment dose-dependently increased intracellular calcium level 
Intracellular calcium, as a ubiquitous second messenger, plays important role in 
regulating cellular activities, such as cell growth, proliferation, and apoptosis 346, 347 . 
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Recent evidence demonstrated that intracellular calcium signaling is linked with obesity, 
adipogenesis and insulin resistance 336-338, 348. Fig 6.1. shows effect of permethrin on 
intracellular calcium level in 3T3-L1 adipocytes. Permethrin treatment (0.01, 0.1, 1, & 10 
µM) dose-dependently increased intracellular calcium level compared to control in 3T3-
L1 adipocytes (p < 0.05).  
 
Figure 6.1. Permethrin dose-dependently increased intracellular calcium level in 3T3-L1 
adipocytes. 3T3-L1 cells were treated with permethrin (10-12 ~ 10-5M) for 6 days of 
differentiation. Intracellular calcium level was measured on day 6 with a fluorescent 
calcium indicator fura-2 in acetyoxymethyl form. Numbers are mean ±SE (n=6). Means 
with different letters are significantly different (p < 0.05). 
6.3.2 Permethrin treatment dose-dependently increased calmodulin (CaM) and 
calcium/calmodulin dependent protein kinase kinase 2 (CaMKKβ) in 3T3-L1 
adipocytes 
Calmodulin is a ubiquitous calcium-binding protein present in all eukaryotic cells 
349. Permethrin treatment (10 µM) significantly increased calmodulin gene expression (p 
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= 0.0123) and protein level (p < 0.05) compared to control in 3T3-L1 adipocytes. 
CaMKKβ plays a role in calcium/calmodulin-dependent (CaM) kinase cascade and acts 
as one of the upstream activators of AMP-activated protein kinase (AMPK) 350. Our 
results showed that permethrin (10 µM) increased both gene expression and protein level 
of CaMKKβ compared to control in 3T3-L1 adipocytes (p < 0.05).  
 
Figure 6.2. Permethrin dose-dependently increased calmodulin (CaM) and 
calcium/calmodulin dependent protein kinase kinase 2 (CaMKKβ) gene expression and 
protein level in 3T3-L1 adipocytes. 3T3-L1 cells were treated with permethrin (0.01, 0.1, 
1, & 10 µM) for 6 days of differentiation. Cells were harvested on day 6. Gene 
expression and protein level of CaM (Fig. 2A & 2C, respectively) and CaMKKβ (Fig. 2B 
& 2D, respectively) were shown. Numbers are mean ± SE (n=3-4). Means with different 
letters are significantly different (p < 0.05). 
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6.3.3 Permethrin treatment significantly increased ER stress  
BiP, a molecular chaperone localized in the lumen of ER, binds to misfolded and 
newly synthesized proteins and prepares them for subsequent folding, oligomerization or 
degradation 339. In addition, Ero1-Lα, an ER membrane-associated N-glycoprotein, is 
also involved in protein folding 351. Both BiP and Ero1-Lα are upregulated under ER 
stress 339, 351. Our results showed that treatment of permethrin (10 µM) significantly 
increased level of BiP and Ero1-Lα (p < 0.05) than control. PERK is an ER 
transmembrane protein kinase that phosphorylates the α subunit of translation initiation 
factor 2 (eIF2α) at Ser 51 in response to ER stress 259. The phosphorylation status of 
PERK and eIF2α is therefore an important marker of the presence of ER stress 259. 
Phosphorylation of eIF2α subsequently induces expression of CHOP, which is another 
downstream marker of PERK and eIF2α pathway under ER stress 352.  Permethrin 
treatment (1 & 10 µM) significantly increased phosphorylation of PERK and eIF2α (p < 
0.05) as well as protein level of CHOP than control (p < 0.05). Another important ER 
stress sensor is inositol-requiring enzyme 1 (IRE1), an ER transmembrane protein that 
can undergo phosphorylation to activate the UPR 353, 354. The phosphorylation of IRE1 
will lead to splicing of X-box binding protein (XBP1) mRNA into transcription factor 
XBP1s, which subsequently increase the synthesis of ER chaperones and phospholipids 
339. Our results showed that permethrin treatment (10 µM) significantly increased 
phosphorylation and protein level of IRE1α than control (p < 0.05). In addition, the level 
of XBP1s is also significantly increased by permethrin (0.1, 1, & 10 µM) than control (p 
< 0.05). Taken together, these results indicated that permethrin treatment significantly 
increased ER stress in 3T3-L1 adipocytes.  
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Figure 6.3. Permethrin induced ER stress in 3T3-L1 adipocytes. 3T3-L1 cells were 
treated with permethrin (0.01, 0.1, 1, & 10 µM) for 6 days of differentiation. Cells were 
harvested on day 6 for immunoblotting. Protein expression of binding immunoglobulin 
protein (BiP, Fig. 3A); endoplasmic reticulum oxidoreductase 1 alpha (Ero1-Lα, Fig. 
3B); phosphorylated RNA-like endoplasmic reticulum kinase (p-PERK, Fig. 3C); PERK 
(Fig. 3D); phosphorylated eukaryotic initiation factor 2 alpha (p-eIF2α, Fig. 3E); eIF2α 
(Fig. 3F); C/EBP homologous protein (CHOP, Fig. 3G); phosphorylated inositol-
requiring enzyme 1 alpha (p-IRE1α, Fig. 3H); IRE1α (Fig. 3I); X-box binding protein 1s 
(XBP1s, Fig. 3J) were shown. Numbers are mean ±SE (n=3-4). Means with different 
letters are significantly different (p < 0.05). 
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6.3.4 Permethrin treatment significantly increased serine phosphorylation of insulin 
receptor substrate 1 
 
 Phosphorylation of IRS1 at Serine 307 is known to cause insulin resistance 325. 
The results showed that permethrin treatment (10 μM) significantly increased p-IRS1 
Ser307 (p < 0.05).  
 
Figure 6.4. Permethrin increased serine phosphorylation of insulin receptor substrate 1 
(IRS1) in 3T3-L1 adipocytes. 3T3-L1 cells were treated with permethrin (0.01, 0.1, 1, & 
10 µM) for 6 days of differentiation. Cells were harvested on day 6 for immunoblotting. 
Protein expression of phosphorylated insulin receptor substrate 1 at Serine 307 (p-IRS1 
Ser307) were shown. Numbers are mean ±SE (n=3-4). Means with different letters are 
significantly different (p < 0.05). 
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6.3.5 Permethrin treatment significantly increased gene expression of inflammatory 
markers 
We further investigated the influence of permethrin treatment on gene expression 
of TNFα, one of the key regulators in inflammatory response. All permethrin treatment 
(0.01, 0,1, 1, & 10 µM) significantly increased TNFα gene expression level than control.  
 
Figure 6.5. Permethrin increased mRNA expression of tumor neocrosis factor α (TNFα) 
in 3T3-L1 adipocytes. 3T3-L1 cells were treated with permethrin (0.01, 0.1, 1, &10 µM) 
for 6 days of differentiation and then RNA were extracted using Trizol solution. 
Extracted RNA were reverse transcribed to cDNA and then real time PCR (RT-PCR) 
were performed. Relative quantities of gene expression with RT-PCR were calculated 
relative to 18S ribosomal RNA. Numbers are mean ±SE (n=3). Means with different 
letters are significantly different (p < 0.05). 
6.4 Discussion 
Results from current study suggest that permethrin increased intracellular calcium 
and ER stress in 3T3-L1 adipocytes. To our knowledge, this is the first report linking 
alteration of calcium and ER stress in 3T3-L1 adipocytes by permethrin treatment.  
The current results showed that permethrin dose-dependently increased 
intracellular calcium level in 3T3-L1 adipocytes. In fact, pyrethroid insecticides were 
known to influence the function of voltage-sensitive calcium channels, resulting in 
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increased calcium influx 18, 333, 334. Permethrin and other pyrethroids (e.g., cyfluthrin, 
deltamethrin) were potent enhancers of both calcium uptake and neurotransmitter release 
via influencing N-type voltage sensitive calcium channels 329, 333. Cismethrin and 
deltamethrin were shown to increase intracellular calcium in rat synaptosomes 333. 
Deltamethrin were also shown to increase intracellular calcium and ER stress in 
neuroblastoma cells 42. As calcium channel α1 subunits is genetically related to the 
voltage-sensitive sodium channel 18, it is likely that permethrin may act directly on the 
VSSC to increase calcium influx.  
Another important intracellular compartment that might contribute to elevated 
intracellular calcium level is the ER. ER serves as an important intracellular calcium store 
with calcium concentration approximately 1000 times higher than in the cytosol 346. The 
calcium concentration in the ER is mainly regulated by three types of proteins: (1) Ca2+ 
pumps [e.g. sacro/endoplasmic-reticulum Ca2+ -ATPase (SERCA)] for uphill transport of 
Ca2+ from the cytosol to the ER lumen; (2) Ca2+ binding proteins [e.g. calsequestrin, 
calreticulin, calnexin, 78-kDa glucose-regulated protein/immunoglobulin heavy chain 
binding protein (GRP78/BiP), GRP94, and various protein disulfide isomerases (PDI)] 
for storage of calcium in the ER and; (3) Ca2+ channels regulating ER calcium release to 
cytosol along its electrochemical gradient [(e.g. ryanodine-receptors (RyR) or the inositol 
1,4,5,-trisphosphate (IP3)-receptors (IP3R)]  
355.  
In normal conditions, the [Ca2+]ER is maintained at a relative stable level to 
prevent ER Ca2+ depletion or overload 355. The release of Ca2+ from ER will trigger a 
series of cellular responses that lead to an increase of Ca2+ entry into the cytosol of the 
cell, a phenomenon known as capacitative calcium entry or “store-operated” Ca2+ entry 
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356. Two key players involved in this process are STIM1 and STIM2 proteins, which are 
ubiquitously expressed transmembrane proteins with a luminal Ca2+ sensor 357, 358. The 
depletion of ER Ca2+ can lead to the oligomerization of STIM1 or STIM2 and interact 
with Orai proteins 358. These tetrameric Ca2+ channels in the plasma membrane are then 
responsible for an increased Ca2+ entry 359-361. Recent evidence shows that ER calcium 
depletion is also linked with ER stress 355.  
In this study, permethrin increased the protein level of Ero1-Lα, an 
oxidoreductase enzyme involved in protein folding by catalyzing the formation and 
isomerization of protein disulfide bonds in the ER of eukaryotes 362. In addition to its role 
in protein folding and oxidation, Ero1-Lα is also involved in regulating ER calcium 
release 351. Upregulation of Ero1-Lα leads to loss of ER calcium and hyper-oxidation of 
ER lumen, which in turn triggers ER stress 351. In this study, we did not measure calcium 
level in the ER. It is likely that permethrin caused ER calcium depletion, which 
subsequently lead to store-operated calcium entry from outside of the cell into the cytosol 
of the cell. 
A large amount of experimental evidence support that ER stress is associated with 
obesity, adipogenesis, and insulin resistance 257-259, 341, 342, 363, 364. Three canonical ER 
stress pathways have been discovered (Fig. 6.6), which are initiated with three different 
ER stress transducers: PERK, IRE1, and activating transcription factor 6 (ATF6). These 
transducers are present in the ER membrane and under normal conditions bind to ER 
chaperones BiP. Increased binding of BiP to luminal misfolded proteins and its 
dissociation from PERK, IRE1, and ATF6, will activate these transducers. PERK 
activation will further phosphorylate eIF2α, which slows protein translation and relieve 
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ER workload. eIF2α phosphorylation induces expression of CHOP, which is involved in 
apoptosis 339. The current results showed that permethrin dose-dependently increased the 
phosphorylation of PERK, eIF2α and the protein level of CHOP. These results indicate 
that permethrin can cause ER stress by activating PERK pathway. As CHOP is linked 
with increased gene expression in inflammatory responses 339. This is consistent with our 
results that permethrin treatment significantly increased TNFα level than control. 
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Figure 6.6. Potential mechanism of permethrin-potentiated adipogenesis and insulin 
resistance in 3T3-L1 adipocytes. Permethrin increases intracellular calcium level and ER 
stress pathway evidenced by elevated protein levels of binding immunoglobulin protein 
(BIP) and endoplasmic reticulum oxidoreductase 1 alpha (Ero1-Lα). Permethrin also 
activates ER stress transducer inositol-requiring enzyme 1 alpha (IRE1α) and protein 
kinase R-like endoplasmic reticulum kinase (PERK). IRE1 activation causes activation of 
Jun N terminal kinase (JNK) and splicing of X-box binding protein (XBP1) mRNA. The 
splicing of XBP1 leads to the translation of transcription factor XBP1s, which upregulate 
ER chaperones, endoplasmic reticulum-associated protein degradation (ERAD), lipid 
biosynthesis and adipogenesis. Activated PERK will further phosphorylate eukaryotic 
translation initiation factor 2 (eIF2α), induces expression of C/EBP homologous protein 
(CHOP), which increases inflammatory responses. Permethrin may activate ATF6, 
leading to similar results as IRE1α-XBP1s pathway.  
IRE1 activation causes splicing of XBP1 mRNA and translation into the 
transcription factor XBP1s 339. XBP1s upregulates ER chaperones, components of the 
endoplasmic-reticulum-associated protein degradation (ERAD) machinery and 
phospholipid biosynthesis 339. The current results indicated that permethrin can activate 
the IRE1-XBP1s pathway as indicated by increased phosphorylation of IRE1 and protein 
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level of XBP1s. In addition, IRE1 can also activates Jun N terminal kinase (JNK) by 
recruiting the scaffold protein tumor necrosis factor receptor-associated factor 2 (TRAF2) 
339. Activated JNK is known to cause insulin resistance via phosphorylation of IRS1 
Ser307 365, 366. This is consistent with our finding that permethrin treatment significantly 
increased phosphorylation of IRS1 at Ser 307. In addition, recent evidence also 
demonstrated that the IRE1α-XBP1s pathway is indispensable for adipogenesis 341.  
Currently, we do not have direct evidence that permethrin treatment potentiated 
adipogenesis via IRE1α-XBP1s pathway. Future studies using IRE1α- or XBP1- deficient 
3T3-L1 adipocytes by permethrin treatment are needed to confirm our hypothesis.  
ATF6 is another ER stress transducer present in the ER membrane. ATF6 can also 
regulate genes involved in ERAD, lipid biosynthesis, and ER expansion in addition to 
IRE1 pathway 339, 367. In this study, we did not measure the markers involved in ATF6 
pathway. As it is also an important pathway for lipid biosynthesis, further studies are 
needed to investigate whether permethrin influence adipogenesis via ATF6.  
In conclusion, our results showed that permethrin may potentiate adipogenesis via 
increasing of intracellular calcium level and ER stress. Future studies are needed to 
investigate the potential role of permethrin on ER stress in vivo. 
  
 124 
 
 
CHAPTER 7 
 
FUTURE DIRECTIONS 
Currently, limited knowledge is known about how dietary fat contributed to 
permethrin’s effect on weight gain and insulin resistance. The current results showed that 
permethrin potentiated weight gain and insulin resistance only in high-fat fed mice. 
Considering permethrin is highly lipophilic, it is likely that the absorption and 
accumulation of permethrin with high-fat diet would be more efficient than with low-fat 
diet. Further investigation on the absorption and accumulation efficacy of permethrin 
when delivered orally in low-fat and high-fat diet are needed.  
Meanwhile, there is a growing evidence showing that early-life exposure to 
insecticides is associated with metabolic disorder later in life 144, 147, 151, 180, 368-370. 
Children are more susceptible to chemical exposure because of higher food and water 
contamination per kilogram body weight, and higher surface-to-volume ratio 371. In 
addition, the metabolic detoxification mechanisms are not fully developed in youth, 
which potentially increase the susceptibility to insecticides 372. The current studies are 
limited to that adulthood exposure to permethrin can potentiate high-fat diet induced 
obesity and type 2 diabetes. Thus, future studies are needed to investigate whether early-
life exposures (e.g. prenatal, neonatal, etc.) can induce metabolic change later in life, 
especially when other factors are present, such as diet, as well as sex dependent 
responses. 
Calcium ions play important role in cellular signaling as well as in adipogenesis 
335. The current results showed that permethrin dose-dependently increased intracellular 
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calcium level in 3T3-L1 adipocytes; however, the mechanism how permethrin induces 
calcium increase remains unclear. Permethrin could directly act on the voltage sensitive 
calcium channel to cause extracellular calcium entry into 3T3-L1 adipocytes followed by 
calcium-induced calcium release from ER 373; permethrin could directly cause calcium 
release from intracellular calcium storage sites (e.g. ER and/or mitochondria) followed by 
store-operated calcium entry from extracellular space 356. Thus, future studies are needed 
to determine the route of permethrin-induced calcium mobilization in adipocytes. In 
addition, the current results demonstrate that permethrin induced ER stress in 3T3-L1 
adipocytes. As elevated intracellular calcium and ER stress are linked with obesity and 
type 2 diabetes in vivo 259, 336, we speculate that permethrin, along with high-fat diet, 
could promote obesity and type 2 diabetes via calcium- and ER stress- mediated 
mechanism in vivo. Future studies are needed to verify our hypothesis.  
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